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Abstract 
 Electrochemical biosensors have been made to detect the metabolic 
markers, pH, O2 and glucose, and nitric oxide (NO), the signalling molecule 
involved in angiogenesis. A novel three-dimensional (3-D) graphene/ionic liquid 
(IL) nanocomposite demonstrates highly sensitive detection of NO in phosphate 
buffered saline (PBS). An arginine-glycine-aspartic acid (RGD) peptide- 
functionalised biomimetic graphene film has been used as both a cell culture and 
sensing matrix to detect NO released by human umbilical vein endothelial cells 
(HUVECs) in real-time under acetylcholine (Ach) stimulation. The amount of NO 
released is dose-dependent and inhibited by NG-nitro-L-arginine methyl ester (L-
NAME). A poly(ethyleneimine) (PEI)-coated anodically electrodeposited iridium 
oxide film (AEIROF) exhibiting super-Nernstian response to pH functions as 
miniature pH sensor for detecting acute changes in extracellular pH due to the 
interaction of porcine aortic ECs (PAECs) with fibronectin and thrombin. 
Thrombin causes dissolution of fibronectin, extracellular acidification of PAECs 
and a change in cell morphology from stretched to round cells. O2 and glucose 
biosensors based on a novel electropolymerised redox polymer are developed and 
prepared by one-step electropolymerisation of methylene blue (MB
+
) and pyrrole 
for the O2 biosensor, with the addition of glucose oxidase (GOD) for the glucose 
biosensor. The O2 biosensor demonstrates superior sensitivity towards dissolved O2 
at atmospheric (atm) O2 concentrations and below and is insensitive to pH. The 
glucose biosensor exhibits direct electron transfer (DET) and is insensitive to pH 
from pH 6 to 8 in N2-purged PBS and from pH 4 to 8 in atm O2 PBS.  
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1 Introduction 
1.1 Background 
 In this chapter, references [1] and [2] are a book chapter and review paper, 
respectively. They are used to describe the process of angiogenesis and its 
implications in pathophysiological conditions as they provide an excellent 
summary of the relevant literature from the 1990s to 2000s.  
 Vasculogenesis and angiogenesis are key processes of vascular 
development which occur sequentially in embryos [1]. During an early phase of 
embryonic development, the cells of the early embryo are partitioned into three 
layers called the ectoderm, mesoderm and endoderm [3]. A subset of the 
mesodermal cells differentiates into endothelial cells (ECs), which assemble to 
form blood islands [1]. The blood islands then connect to form a primary vascular 
network and this process is called vasculogenesis [4]. The primary vascular 
network expands to form new vessels by two distinct mechanisms - sprouting 
angiogenesis and non-sprouting angiogenesis (Figure 1.1) [5]. In sprouting 
angiogenesis, ECs of existing primary vascular channels form elongated features 
called sprouts which invade the proximal space, interact with other sprouts and 
fuse together to form new vascular channels [1]. During non-sprouting 
angiogenesis, mesenchymal cells surrounding each EC of an existing vascular 
channel push the EC inwards, causing the vascular channel to be divided into two, 
forming two new vascular channels [1].  
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Figure 1.1 (a) In sprouting angiogenesis, a new vascular channel is formed by 
fusing two primary vascular channels. (b) In non-sprouting angiogenesis, each 
primary vascular channel divides to form two new vascular channels.  
 
These two processes synergistically give rise to complex vascular channels, which 
undergo pruning, remodelling and maturation to form blood vessels [5]. These 
blood vessels are then infiltrated by pericytes and smooth muscle cells which 
provide mechanical support and ability of these blood vessels to contract [6].  
 Transforming growth factor β is considered a major regulator of 
vasculogenesis by mediating the production of extracellular matrix (ECM) 
macromolecules such as fibronectin and laminin [7]. Little is known about other 
factors which regulate vasculogenesis [1]. Angiogenesis has been more extensively 
studied. Fibronectin [8], laminin [9] and integrins [10] have been suggested to play 
major roles in ECM remodelling during the formation of new vascular channels. A 
soluble factor, vascular endothelial growth factor (VEGF), and its family of 
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receptors have been identified as one of the key regulators of angiogenesis [11]. 
During oxygen deprivation (hypoxia), hypoxia inducible factors (HIFs) cause the 
production of VEGF in ECs to promote angiogenesis to increase the supply of O2 
to neighbouring cells [12]. There are other factors which mediate vascular channel 
formation. These include the so-called fibroblasts growth factor (FGF) [13, 14], 
Delta-like ligand 4 (Dll4) and the Notch1 receptor [15, 16], as well as 
angiopoietins (Ang) and the Tie2 receptor family [17, 18]. The platelet-derived 
growth factor (PDGF) family is found to be responsible for the recruitment of 
pericytes and smooth muscle cells to provide structural integrity and contraction 
ability in the blood vessels [19, 20].      
 The crosstalk between EC metabolism and angiogenesis was highlighted by 
Fraisl et al. [21]. The extracellular environment presents stimuli which affect the 
metabolism of the cell, triggering various series of intracellular events which 
influence angiogenesis. For example, hypoxia increases anaerobic glycolysis in 
ECs [21]. H
+
 produced during glycolysis are pumped out of the cell to maintain 
intracellular pH, thereby causing extracellular pH to fall. In addition, HIFs are 
activated and nitric oxide (NO), a potent signalling molecule of angiogenesis, is 
produced. NO modulates the expression of VEGF and its receptors within the cell. 
VEGF is released and diffuses to the neighbouring ECs, where it elicits effects on 
ECs with VEGF receptors present on their cell membrane. These ECs respond to 
the VEGF gradient and migrate towards it, eventually forming new blood vessels 
[22].    
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 Perturbation of angiogenesis disrupts the delicate balance of blood flow, 
metabolism, as well the structural integrity of tissues [2]. Angiogenesis is thus 
implicated in diverse pathophysiological conditions such as chronic wounds [23], 
rheumatoid arthritis [24] and cancers [25]. ECs in chronic wounds express high 
amounts of protease, which damage the ECM macromolecules, thereby delaying 
wound-healing [23]. In arthritis, the growth of blood vessels and nerves at the 
normally vessel-free joint leads to inflammation and chronic pain [24]. A protein 
called "oncogenic Ras" plays a critical role in tumour angiogenesis in cancers [26]. 
Ras can be activated by NO which is produced during hypoxia, as well as during 
tumour acidosis and signals through two independent pathways to upregulate 
VEGF production. In addition, Ras induces the expression of cycloxygenase-2 in 
tumours, which induces the upregulation of pro-angiogenic factors such as FGF-2, 
PDGF and VEGF. The increase in these pro-angiogenic factors by tumour cells 
and/or host cells enhances the growth of new blood vessels and persistent 
angiogenesis results in defective blood vessels which are disorganised and leaky 
[6]. The morphology of these new blood vessels differ in different carcinomas, 
suggesting that different angiogenic factors were involved [2].  
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1.2 Motivations 
 Angiogenesis is a multistage process involving the formation of blood 
vessels from pre-existing ones. It is a highly complex, dynamic and heterogeneous 
process which involves the interaction of multiple pathways and its mechanisms 
may differ in various developmental stages in different organs [1]. Arterial, venous, 
lymphatic and haemogenic ECs, organ-specific ECs and circulating endothelial 
progenitor cells are some of the members of the heterogeneous EC population [1, 
27], making the study of angiogenesis complicated. Studies on the mechanisms of 
angiogenesis have rarely been achieved in real-time, so the proposed mechanisms 
are highly speculative and inconclusive.  
 Angiogenesis is also implicated in diverse pathophysiological conditions 
such as chronic wounds [23], rheumatoid arthritis [24] and cancers [25]. 
Assessments of vascular density by magnetic resonance imaging [28], Doppler 
ultrasound [29], nuclear medicine imaging [30], perfusion computed tomography  
[31] and the immunodetection of circulating biomarkers VEGF and FGF-2 [32] are 
some of the techniques which have been applied to identify tumour angiogenesis in 
vivo. However, these approaches may not yield conclusive results due to the 
complexity of factors involved and variations in their temporal, heterogeneous 
release during different stages of a disease [2]. It is also difficult to determine if the 
upregulation of angiogenic factors causes tumour progression, or the other way 
around. Hence, these studies have provided little clue to the mechanisms for 
pathophysiological angiogenesis.  
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 The extracellular environment of ECs and its intracellular mechanisms 
control the crosstalk between angiogenesis and EC metabolism [21]. External 
stimuli such as growth factors, changes in O2 levels and drugs cause ECs to 
become activated, eliciting acute cellular responses which often involve a change 
in EC metabolism. Hence, level of signalling molecules such as NO and metabolic 
markers such as O2, CO2, glucose, lactate and pH are expected to become affected. 
However, these changes are under-investigated. Since there is crosstalk between 
EC metabolism and angiogenesis [21], comparing the metabolism of ECs during 
physiological conditions and under the influence of ECM macromolecules, soluble 
factors, drugs or pathophysiology can provide some insights on how these 
influences affect angiogenesis in order to elucidate their individual and combined 
effects. In particular, there is an urgent need to study these complex interactions in 
real-time in order to understand the short-term causes and effects on angiogenesis, 
which has been difficult to achieve using conventional biological techniques.    
 
1.3 Objective and specific aims  
 Electrochemistry was selected as the experimental approach in order to 
meet the objective of acquiring real-time, quantitative data in a non-destructive 
manner to understand the effects of external stimuli on the metabolism of ECs and 
their relationships to angiogenesis. Nanomaterials were used to construct 
electrochemical biosensors suitable for the real-time, quantitative detection of 
extracellular metabolic markers, pH, O2 and glucose, as well as the signalling 
28 
 
molecule, NO. This is the first step towards establishing the interactions of soluble 
factors, ECM macromolecules, EC metabolism and angiogenesis in real-time.  
 Different platforms were used for ECs studies, which were subjected to the 
availability of resources at each university. Hence, the specific aims were set for 
the experiments which could be performed at each university.  
 At NTU, the aim is to develop high performance novel graphene-based 
nanostructured materials for the detection of NO. This involves the use of a three-
dimensional (3-D) graphene/ionic liquid (IL) nanocomposite to fabricate a NO 
biosensor. In addition, it includes the construction of a biomimetic graphene film 
for the cell culture of human umbilical vein endothelial cells (HUVECs) and 
detection of NO released by these cells under the stimulation of acetylcholine 
(Ach).  
 At Imperial College London, microelectrode array (MEA) chips are 
available and the aim is to use anodically electrodeposited iridium oxide film 
(AEIROF) as a miniature pH biosensor on a chip to study the acute changes in 
extracellular pH of porcine aortic endothelial cells (PAECs) cultured on fibronectin 
due to the stimulation of thrombin.  
 A collaborative effort between the two universities involves the 
development of O2 and glucose biosensors based on a novel electropolymerised 
redox polymer film, with the intention of miniaturising these biosensors on a chip 
in future.    
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2 Review of literature 
2.1 Key regulators of angiogenesis 
 Cells experiencing hypoxia need to restore their supply of O2 in order 
maintain basic cell functions like cellular respiration. Most human cells, including 
endothelial cells (ECs), contain at least one type of hypoxia inducible factor (HIF), 
an intracellular O2 sensor, which is activated during hypoxia [12]. In ECs, this 
leads to the production and release of vascular endothelial growth factor (VEGF) 
[33]. VEGF binds to its receptors on neighbouring ECs, resulting in intracellular 
cascades which trigger angiogenesis. ECs proliferate and migrate towards the 
source of the VEGF and pericytes and smooth muscles cells are recruited for the 
formation of new blood vessels for the restoration of O2 supply [6].   
 
2.1.1 Hypoxia inducible factors (HIFs) 
 The HIF transcription factors HIF-1 and HIF-2, each of which consists an α 
and β subunit, upregulate angiogenesis independently during hypoxia (Figure 2.1) 
[12]. Hydroxylation of the α subunit is catalysed by protein hydroxylase domain 
containing protein 2 (PHD-2) in the presence of O2 [12]. The hydroxylated α 
subunit is transcriptionally inactive and ubiquitinated for proteolytic degradation 
[34].  
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Figure 2.1 Crosstalk exists between EC metabolism and angiogenesis (Chapter 
2.2). The EC utilises glycolysis to generate its energy. Glucose is transported into 
the EC by a glucose transporter (GLUT) and is converted into pyruvate via 
glycolysis. The H
+
 produced during glycolysis are pumped out of the cell by the 
H
+
/ATPase, causing extracellular acidification. Pyruvate is then converted to 
lactate. The presence of lactate and the lack of O2 during hypoxia causes PHD-2 to 
be inhibited, allowing HIF-1 and HIF-2 to enter the nucleus and bind to DNA. HIF-
1 causes the expression of inducible nitric oxide synthase (iNOS) and VEGFA 
while HIF-2 results in the expression of endothelial nitric oxide synthase (eNOS) 
and VEGFR2. The enzymes eNOS and iNOS produce NO, which increases cell 
permeability. Low concentrations of NO inhibit cytochrome c oxidase (CcO) in the 
mitochondrion to allow the redistribution of O2 within the EC.   
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 During hypoxia, PHD-2 becomes inactive due to the lack of O2. In addition, 
lactate produced during anaerobic respiration also inhibits PHD-2 (Chapter 2.2). 
Therefore, the α subunit of HIF is stabilised, with HIF-1α requiring a higher degree 
of hypoxia than HIF-2α to be stabilised [35]. The α subunit then dimerises with its 
β subunit. The stabilised HIF-1 enters the nucleus of the EC and binds to 
deoxyribonucleic acid (DNA), upregulating the expression of vascular endothelial 
growth factor A (VEGFA) [36] and inducible nitric oxide synthase (iNOS), which 
catalyses the reaction between O2 and L-arginine, producing NO [37]. The binding 
of HIF-2 to DNA results in the expression of a VEGF receptor called VEGFR2 
(Chapter 2.1.2) [38]. While inhibiting NO production via the expression of arginase 
(an enzyme which breaks down L-arginine), HIF-2 fosters the generation of NO 
through endothelial nitric oxide synthase (eNOS), which enhances EC permeability 
for VEGFA-induced angiogenesis [37].  
 The concentration of endothelial NO affects the stability of HIF-1α and 
therefore cell signalling [12]. NO has higher affinity than O2 towards cytochrome c 
oxidase (CcO), which is found in the mitochondrion [39]. During hypoxia, the 
concentration of endothelial NO increases and below 400 nM, NO inhibits CcO 
and therefore cellular respiration [39, 40]. This leads to redistribution of O2 within 
the cell. As intracellular O2 increases, the activity of O2-dependent enzymes, 
including PHD-2, is restored and HIF-1α is destabilised [41]. However, at higher 
concentrations of endothelial NO, such as that seen in pathophysiology, HIF-1α is 
stabilised by NO via S-nitrosylation [42], irrespective of O2 concentration [40].  
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2.1.2 Vascular endothelial growth factor (VEGF) family 
 The VEGF family consists VEGFA, VEGFB, VEGFC, VEGFD, VEGFE 
and placental growth factor, which are key regulators of angiogenesis [43]. 
VEGFA is a positive regulator of angiogenesis [6]. The gene encoding human 
VEGFA can undergo alternative splicing to give rise to 4 different isoforms, 
namely VEGF121, VEGF165, VEGF189 and VEGF206, where the numbers in 
subscript indicate the amino acids forming each of the VEGF isoforms following 
the removal of the signal peptide [44, 45]. VEGF189 and VEGF206 are able to bind 
to heparin and are retained in the ECM. In contrast, VEGF121 is not bound to the 
ECM as it does not bind to heparin and diffuses freely to interact with other cells. 
VEGF165 has properties intermediate of the other types of VEGF, with some of it 
being secreted and the bulk of it remaining bound to the ECM [46].  
 
2.1.2.1 Receptors of VEGF family  
 There are three different receptors on the surface of ECs, namely VEGFR1, 
VEGR2 and VEGFR3, to which various members of the VEGF family can bind to 
trigger intracellular signalling cascades [11, 43]. VEGFR1 and VEGFR2 are 
involved in angiogenesis and interact with VEGFA while VEGFR3 participates in 
the formation of lymphatic vessels from pre-existing ones and interacts with 
VEGFC and VEGFD [6]. These receptors are members of the receptor tyrosine 
kinase superfamily and are transmembrane proteins. 7 immunoglobulin-like 
(antibody-like) units, Ig I to Ig VII, form the extracellular domain of the VEGFR 
and two tyrosine kinase fragments, TK-1 and TK-2, make up the intracellular 
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domain of VEGFR [47]. When the ligands bind to their corresponding receptors, 
the receptor dimerises and its intracellular domain possessing tyrosine kinase 
activity undergoes transphosphorylation or autophosphorylation [6].     
 VEGFR1 primarily functions as a negative regulator of the activity of 
VEGFA on VEGFR2 [6, 43]. The soluble form of VEGFR1 binds to VEGFA and 
hence reduces the binding of VEGFA to VEGFR2, which mediates most of the 
angiogenic effects of VEGFA on ECs [48]. Pigment epithelium-derived factor 
(PEDF) also inhibits angiogenesis by enhancing the γ-secretase activity of ECs, 
resulting in increased cleavage of the transmembrane domain of VEGFR1 [49].  
 VEGFR2 is the primary mediator of VEGFA‟s activity for angiogenesis 
and its activation stimulates EC proliferation, survival and migration [2, 6]. The 
activation of VEGFR2 elicits several intracellular signalling pathways (Figure 2.2). 
The protein kinase C (PKC)/extracellular receptor kinase (Erk) is initiated by the 
autophosphorylation of the tyrosine residues, Tyr1175, of the intracellular domain 
of VEGFR2 [50]. Erk translocates to the nucleus and phosphorylates c-Jun, a 
transcription factor. C-fos is transcribed and causes EC proliferation [2]. The 
activation of the VEGFR2-dependent phosphatidylinositol 3-kinase (PI3K)/protein 
kinase B (PKB) inhibits caspase activity by upregulating anti-apoptotic proteins A1 
and Bcl-2, leading to cell survival [51]. EC migration is facilitated by the p38 
mitogen-activated protein kinase (MAPK) pathway and focal adhesion kinase 
(FAK) which phosphorylates paxillin, causing cytoskeleton reorganisation [52]. In 
addition, the activation of GTP-binding protein Rac by phosphatidylinositol 
(3,4,5)P3 (PIP3) also aids in cell migration [53]. The activation of VEGFR2 also 
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stimulates eNOS to produce NO, which enhances EC proliferation and migration 
[54]. 
 
Figure 2.2 Binding of VEGFA to VEGFR2 triggers several intracellular signalling 
pathways in the EC, which produces NO, as well as proteins needed for cell 
survival, proliferation and migration. 
   
2.1.3 Delta-like ligand 4 and Notch signalling  
 Notch receptors are a family of transmembrane, heterodimeric proteins 
[55]. Notch1 and Notch4 receptors and their transmembrane ligands, Jagged1 and 2 
and Delta-like ligand 1 (Dll1) and Dll4, are expressed in vascular ECs [6]. The 
intercellular contact formed by the binding of the ligand to the extracellular 
domains of Notch receptor (Figure 2.3a) results in the proteolytic cleavage of the 
receptor at two sites [56]. Firstly, the extracellular domain of the Notch receptor is 
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cleaved and uptaken by an adjacent cell which also expresses the ligand (Figure 
2.3b) [6]. Secondly, intracellular domain of the Notch receptor is cleaved and 
translocates to the nucleus, where it binds to DNA and alters gene expression [57].  
 
Figure 2.3 (a) The EC expresses VEGFR2 when the intracellular domain of the 
Notch1 receptor is together with its extracellular domain at the cell membrane. The 
extracellular domain of the Notch1 receptor comes into contact with Dll4 of an 
adjacent cell. (b) The Notch1 receptor is cleaved by an enzyme into its two 
domains. The extracellular domain is uptaken by the adjacent cell while the 
intracellular domain enters the nucleus and binds to DNA, inhibiting the expression 
of VEGFR2.  
  
 Dll4 and the Notch1 receptor are involved in regulating the activation of tip 
cells, a group of ECs at the leading site of new blood vessels [58]. The tip cells 
express high levels of VEGFR2 and respond to the VEGFA gradient by sprouting 
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elongated structures called filopodia and growing towards it [59]. ECs expressing 
the Notch1 receptor are activated by Dll4 and the signalling cascade prevents the 
activation of these cells into tip cells by limiting the expression of VEGFR2 
(Figure 2.3), causing a decrease in sensitivity towards VEGFA [58]. However, ECs 
in the growing capillary branch are stimulated to proliferate by the binding of 
VEGFA to VEGFR2, highlighting that VEGFA is able to independently control the 
migration of tip cells as well as the proliferation of ECs [59].  
 
2.1.4 Angiopoietins (Ang) and Tie receptors  
 Angiopoietin1 (Ang1) and Ang2 are glycoproteins which are ligands of the 
Tie1 and Tie2 tyrosine kinase receptors [60]. These receptors are expressed 
exclusively in ECs. The role of the Tie1 receptor, while distinct from that of the 
Tie2 receptor [17], is still not well understood [60]. None of the ligands bind to the 
Tie1 receptor. It interacts with the Tie2 receptor and is activated when Ang1 binds 
to the Tie2 receptor [61]. Ang1 is expressed by mesenchymal cells and smooth 
muscle cells and it binds to and activates the Tie2 receptor expressed on ECs, 
leading to the recruitment of pericytes and giving structural support to the blood 
vessels (Figure 2.4a) [62]. Ang2 functions as a competitive inhibitor of Ang1 and 
binds to the Tie2 receptor, but does not result in the phosphorylation of the receptor 
unlike Ang1 [63]. However, Ang2 elicits different biological actions in the absence 
and presence of VEGFA, leading to vascular regression (cell death) (Figure 2.4b) 
and angiogenesis (cell survival, proliferation and migration) (Figure 2.4c), 
respectively, for vascular remodelling [62]. The inhibition of the Ang1/Tie2 
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signalling by Ang2 causes the destabilisation of capillaries without the recruitment 
of pericytes, which in turn makes the ECs hypersensitive to the pro-angiogenic 
effect of VEGFA [63]. 
 
Figure 2.4 (a) The binding of Ang1 to the Tie2 receptor causes the recruitment of 
pericytes. (b) In the absence of VEGFA, the binding of Ang2 to the Tie2 receptor 
causes cell death for vascular regression. (c) In the presence of VEGFA, the 
binding of Ang2 to the Tie2 receptor leads to cell survival, proliferation and 
migration for the growth of blood vessels.   
 
2.1.5 Platelet-derived growth factor family (PDGF) 
 The PDGF family comprises four different PDGF strands which can form 
the homodimers PDGF-AA, PDGF-BB, PDGF-CC and PDGF-DD or heterodimer 
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PDGF-AB [64]. The PDGF receptors, homodimers PDGFRα and PDGFβ and 
heterodimer PDGFRαβ, are also tyrosine kinase receptors. PDGF-AA binds 
exclusively to PDGFRα while PDGF-BB binds with high affinity to PDGFRβ but 
with lower affinity to PDGFRα and PDGFRαβ [65]. PDGF-CC binds to both 
PDGFRα and PDGFRβ while PDGF-DD binds to PDGFRαβ only. During 
angiogenesis, the expression of PDGFB is high in tip cells and this recruits 
pericytes and vascular smooth muscle cells expressing PDGRFβ on their surfaces 
to form the walls of new blood vessels and these blood vessels undergo maturation 
[59]. PDGFRβ is not expressed in ECs so PDGFB does not have any effect on 
them [66].   
 
2.2 Extracellular metabolic (O2, CO2, pH, glucose, lactate) and signalling 
(NO) markers of angiogenesis 
 O2, CO2, pH, glucose and lactate are key extracellular metabolic markers 
while NO is a signalling molecule of angiogenesis. Metabolic rate of the cell can 
be measured by the rate of uptake of reactants such as O2 and glucose, or by the 
rate of release of products like CO2 and lactate, which contribute to extracellular 
acidification [67]. Fraisl et al. had highlighted the crosstalk between EC 
metabolism and angiogenesis [21]. In normoxic healthy tissue, ECs exist as 
quiescent cells. However, they are also adapted with metabolic mechanisms which 
enable them to survive hypoxia during sprouting angiogenesis. During normoxia, 
resting ECs utilise primarily glycolysis instead of oxidative phosphorylation to 
generate adenosine triphosphate (ATP), allowing most of the O2 to diffuse through 
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them to the surrounding tissue. A little of the pyruvate produced enters the 
mitochondrion and the bulk of it is converted to lactate, which inhibits PHD-2 
(Figure 2.1) [12]. This causes HIFs to be active and results in a positive feedback 
loop that favours glycolysis since the intracellular O2 concentration is low.  
 During hypoxia, migrating ECs also generate ATP through glycolysis and 
pyruvate does not enter the mitochondrion and is converted to lactate (Figure 2.1) 
[12]. HIFs are also active since PHD-2 is inhibited by both hypoxia and lactate, 
thereby greatly accelerating glycolysis. While oxidative phosphorylation of ECs 
are inhibited under hypoxia, they still consume O2 as O2 is needed for the 
production of NO, which increases cell permeability [37] and stimulates cell 
proliferation and migration [54] during VEGFA-induced angiogenesis. In addition, 
more H
+
 are present intracellularly as a result of increased glycolysis. These are 
removed via the H
+
/ATPases to maintain intracellular pH, causing a decrease in 
extracellular pH [21]. Hence, we can see that the interplay of metabolic markers 
and NO is important in angiogenesis.  
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2.3 Electrochemical detection 
2.3.1 Electrochemical cell 
 An electrochemical cell is typically made up of an ion-conducting 
electrolyte solution and three electrodes [68]. The electrolyte solution e.g. aqueous 
KCl has high ionic conductivity which minimises solution resistance. The three 
electrodes are called the reference electrode, working electrode and counter 
electrode. The reference electrode has constant potential and can be a Ag|AgCl or 
saturated calomel electrode. The electrochemical reaction occurs at the working 
electrode-solution interface. The counter electrode allows the current to flow from 
the working electrode but does not interfere with the reaction at the working 
electrode.  
 
2.3.2 Mass transport  
 Mass transport of the electroactive species (dissolved in the electrolyte 
solution) to the working electrode's surface can occur by three different ways or a 
combination of these ways [69]. These include diffusion (movement of the species 
down its concentration gradient), migration (movement of charged species due to 
an electric field) and convection (movement of species due to a density gradient or 
stirring). The one-dimensional flux, 𝐽 𝑥  (mol cm-2 s-1), of an electroactive species 
to the electrode's surface can be described by the Nernst-Planck equation [69] as  
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𝐽 𝑥 = −𝐷
𝜕𝐶(𝑥)
𝜕𝑥
−
𝑧𝐹
𝑅𝑇
𝐷𝐶
𝜕∅(𝑥)
𝜕𝑥
+ 𝐶𝑣(𝑥) 
 where D (cm
-2
 s
-1
) is the diffusion coefficient of the electroactive species, 𝐶 𝑥  
(mol cm
-3
) is its concentration, z is its charge and 𝑣 𝑥  (cm s-1) is the rate of 
movement of the volume element in the solution. R is the gas constant (8.314 J 
mol
-1
 K
-1
)  and F is Faraday's constant (96485 C mol
-1
). 
𝜕𝐶(𝑥)
𝜕𝑥
 is the concentration 
gradient and 
𝜕∅(𝑥)
𝜕𝑥
 is the electrical potential gradient. The first term of the equation 
describes diffusion of the electroactive species, the second term the migration of 
the charged electroactive species, and the third term the convection of the solution. 
Migration of charged electroactive species in an electric field is prevented by using 
a dilute concentration of electroactive species e.g. 10 mM [Fe(CN)6]
4- 
and a
 
high 
concentration of electrolyte solution e.g. 1 M aqueous KCl solution.  
 
2.3.3 Steps in a simple electrochemical reaction 
 For a simple electrochemical reduction reaction, we begin with a solution of 
inert electrolyte containing an electroactive species (O) in oxidised state. The 
working electrode is held at a potential sufficiently negative from the equilibrium 
potential to reduce O. O diffuses from the bulk solution to the working electrode. 
Electron transfer occurs where the number of e
-
 transferred per mole of O is given 
by n as O is reduced to R. R diffuses from the surface of the electrode and into the 
bulk solution.  
𝑂 + 𝑛𝑒− ↔ 𝑅 
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The diffusive flux, J (mol cm
-2
 s
-1
), of O to the electrode surface is related to the 
current, i (A), where n is the number of e
-
 transferred, F is Faraday's constant 
(96485 C mol
-1
) and A is the area of the electrode (cm
2
) [70, 71].  
𝐽 =  
𝑖
𝑛𝐹𝐴
 
When the species O and R are near the electrode surface, they can adsorb on the 
electrode surface and/or react with species before or after electron transfer.  
  
2.3.4 Nernst equation  
 The Nernst equation [69] describes the equilibrium potential, E (V), of an 
electrochemical cell with fast kinetics and reversible reaction at the surface of the 
working electrode as    
𝐸 = 𝐸0 +
𝑅𝑇
𝑛𝐹
𝑙𝑛
𝑎𝑂
𝑎𝑅
 
where E
0
 (V) is the standard potential, R is the gas constant (8.314 J mol
-1
 K
-1
), T is 
the temperature (K), F is Faraday's constant (96485 C mol
-1
), n is the number of e
-
 
transferred, 𝑎𝑂  (mol L
-1
) is the activity of the oxidised species and 𝑎𝑅  (mol L
-1
) is 
the activity of the reduced species.  
 If the activity coefficients of both the oxidised and reduced species are 
unity, the Nernst equation can be simplified as 
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𝐸 = 𝐸0′ +
𝑅𝑇
𝑛𝐹
𝑙𝑛
𝑐𝑂
𝑐𝑅
 
where E
0'
 is the formal potential and cR and cO are the bulk concentration of the 
reduced and oxidised species (mol L
-1
), respectively.  
 
2.3.5 Cyclic voltammetry  
 Cyclic voltammetry (CV) is an electroanalytical technique in which the 
working electrode potential is ramped (Figure 2.5a) and the resulting current is 
measured and current is plotted against the potential (Figure 2.5b).  The magnitude 
of the electron transfer current rises as potential initially increases as the rate is 
exponentially-dependent on the potential and reaches a maximum at the peak 
potential, as current is limited by mass transport and electron transfer, the 
concentration gradient becomes steeper [72]. The magnitude of the anodic peak 
current is ip,a and that of the cathodic peak current is ip,c. The magnitude of the 
current decreases beyond the peak potential and attains a concentration gradient 
that is constant at high overpotential due to natural convection [72]. The scan rate 
(v) also affects the current response, with higher v resulting in a higher current due 
to greater capacitative charging and increase of redox current proportional to v
1/2 
since less time is available for the surface concentrations
 
as a result of a complex 
function of current to time-dependent change of potential [72].  
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Figure 2.5 (a) A potential ramp with v =  0.05 Vs
-1
 and (b) the resulting CV curve 
showing current response/µA against potential/V for 10 mM of [Fe(CN)6]
4-
 in 1 M 
aqueous KCl solution at a Au electrode. The experimental value of ∆Ep is 0.065V. 
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 For a redox-active species such as [Fe(CN)6]
4-/3-
 with reversible 1 e
-
 
transfer, a pair of peaks is observed in the CV (Figure 2.5b). On the forward scan 
from -0.1V to 0.7V vs Ag|AgCl, an anodic peak at Ep,a corresponding to the 
oxidation of [Fe(CN)6]
4-
 to [Fe(CN)6]
3- 
is observed and
 
on the reverse scan from 
0.7V to -0.1V, a cathodic peak at Ep,c for the reduction of [Fe(CN)6]
3-
 to 
[Fe(CN)6]
4- 
is seen.  The peak separation (∆Ep) of the reversible reaction is given 
by  Ep,a - Ep,c or 
0.059𝑉
𝑛
 at 298 K, where n is the number of e
-
 transferred. The formal 
potential (E
0'
) can be estimated as 
𝐸𝑝 ,𝑎 +𝐸𝑝 ,𝑐
2
 if the diffusion coefficients of the 
oxidised and reduced species are similar. In addition,  
𝑖𝑝 ,𝑎
𝑖𝑝 ,𝑐
 = 1 and Ep,a and Ep,c are 
independent of scan rate. The Randles-Sevc ik equation [73] describes the anodic 
peak current, ip,a (A), of a diffusion-controlled, reversible reaction at a planar disk 
electrode as 
𝑖𝑝 ,𝑎 = 2.69 × 10
5  𝐴 𝑐𝑅 𝑛
3
2 𝐷𝑅
1
2 𝑣
1
2   
where A is the area of the electrode (cm
2
), cR is the bulk concentration of the 
reduced species (mol cm
-3
), n is the number of e
-
 transferred, DR is the diffusion 
coefficient of the reduced species (cm
2
 s
-1
) and v is the scan rate (V s
-1
).   
 However, for a quasi-reversible or irreversible reaction, electron transfer is 
sluggish [73]. A larger overpotential needs to be applied to obtain the same rate of 
electron transfer, causing the peaks to broaden and ∆Ep to be larger than 
0.059𝑉
𝑛
 at 
298 K, where n is the number of e
-
 transferred [69]. In addition,  
𝑖𝑝 ,𝑎
𝑖𝑝 ,𝑐
 ≠ 1. The 
equation for the anodic peak current (A) becomes 
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𝑖𝑝 ,𝑎 = 2.99 × 10
5  𝐴 𝑐𝑅 𝑛(𝛼𝑛𝑎)
1
2 𝐷𝑅
1
2 𝑣
1
2   
where α is the transfer coefficient and nα is the number of e
-
 involved in the rate-
limiting charge transfer step. For a totally irreversible reaction, the cathodic peak is 
not present. Ep,a will shift positively by 
1.5𝑅𝑇
𝛼𝑛𝐹
 or 
30
𝛼
 mV at 298 K per ten-fold 
increase in v [74].  
 
2.3.6 Amperometry 
 In amperometry, the working electrode is stepped from a potential (Ei) of 
zero faradaic current to a potential (Es) where the kinetic of charge transfer is so 
fast that the surface concentration of the electroactive species O is effectively zero 
and the rate of reaction becomes limited by mass transport (Figure 2.6) [69].The 
potential is either maintained at Es or stepped to a final potential (Ef) as in double 
potential step chronoamperometry [75]. The resulting mass transport-limited 
current (𝑖𝑙) is given by  
𝑖𝑙 = 𝑛𝐹𝐴𝑚𝐶𝑜 =
𝑛𝐹𝐴𝐷𝑜𝐶𝑜
𝛿
 
where n is the number of e
-
 involved in the rate-limiting charge transfer step, F is 
Faraday's constant (96485 C mol
-1
), A is the area of the electrode (cm
2
), m is the 
mass transport coefficient (cm s
-1
), Co is the bulk concentration of the electroactive 
species O (mol cm
-3
), Do is the diffusion coefficient of the electroactive species O 
(cm
2
 s
-1
) and 𝛿 (cm) is the thickness of the Nernst diffusion layer.  
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Figure 2.6 (a) The Au microelectrode was stepped from Ei = 0.75V to Es = 0V to Ef 
= 0.75V. (b) The corresponding current response of the electrode to the applied 
potential steps in 10 mM ferric ammonium sulphate in 0.5 M aqueous HClO4 
solution.  
(a) 
(b) 
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In an unstirred solution, the current measured at the planar disk electrode decays 
over time according to the Cottrell equation [69]  
𝑖 𝑡 =
𝑛𝐹𝐴𝐷𝑜
1/2𝐶𝑜
𝜋1/2𝑡1/2
 
where t is time in seconds.  
  
2.3.7 Electrochemical impedance spectroscopy 
 In electrochemical impedance spectroscopy (EIS), a small amplitude, 
sinusoidal potential 𝐸 = ∆𝐸 𝑠𝑖𝑛 2𝜋𝑓𝑡 is applied over a range of frequencies (f), 
typically from 10
-2
 to 10
4
 Hz, to the working electrode and the resulting current 
𝑖 = ∆𝑖 𝑠𝑖𝑛 (2𝜋𝑓𝑡 + ∅), where ∅ is the phase shift, is measured [68]. The 
impedance 𝑍 =
𝐸
𝑖
 is a complex quantity and the imaginary part of Z is plotted 
against its real part in an Argand diagram.  
 A simple electrochemical reaction  𝑂 + 𝑛𝑒− ↔ 𝑅 can be modelled as a 
circuit (Figure 2.7a) consisting an uncompensated resistance (Ru), charge transfer 
resistance (Rct), Warburg impedance and double layer capacitance (Cdl) and its 
Argand diagram (Figure 2.7b) is shown on the next page 
 
 
 
49 
 
 
 
Figure 2.7 (a) The equivalent circuit for a simple electrochemical reaction 𝑶 +
𝒏𝒆− ↔ 𝑹. (b) The corresponding Argand diagram. 
 
 
 
(a) 
(b) 
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A semi-circle is observed at high frequencies where the kinetics of electron transfer 
is rate-limiting and a straight line is seen at low frequencies where the reaction is 
diffusion-limited. Ru (Ω) is given by the intersection of the curve with the Zreal axis 
at high frequency and Rct (Ω) is the diameter of the semicircle. Cdl (F) is obtained 
from the maximum of the semicircle where  
𝑓 =
1
2𝜋𝑅𝑐𝑡𝐶𝑑𝑙
 
The exchange current density, j0 (A cm
-2
), can be calculated by the equation 
𝑗0 =
𝑅𝑇
𝑛𝐹𝑅𝑐𝑡
 
where R is the gas constant (8.314 J mol
-1
 K
-1
), T is the temperature (K), n is the 
number of e
-
 involved in the rate-limiting charge transfer step, F is Faraday's 
constant (96485 C mol
-1
). 
 
2.4 Nanomaterials for electrochemical biosensors  
 Electrochemical biosensors function by the principles of electrochemistry 
and the specificity of biological interactions. The biotransducer catalyses an 
electrode reaction involving the analyte, leading to a quantitative electrical 
response proportional to the concentration of the analyte, thereby allowing the real-
time detection of the biological event [73]. Electrochemical biosensors are divided 
into two categories – biocatalytic devices which employ immobilised enzymes, 
cells or tissues as their biocomponents and affinity sensors which utilise antibodies, 
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membrane receptors or nucleic acids [73]. This dissertation focuses on the first 
type of biosensors, which are discussed in greater detail in the following sections.  
 Conventional electrodes are made up of bulk material such as Pt, Au or 
glassy carbon (GC). However, the rise of nanomaterials in recent years has opened 
the exploration of novel electrode materials with superior performances with high 
sensitivities, low detection limits and excellent selectivities. These properties are 
attributed to nanomaterials having high surface area-to-volume ratio and tunable 
electron transport which promote direct and efficient electron transfer [76]. Surface 
modification of nanomaterials alters their functional groups, which can improve 
their properties and/or allow them to be combined with other nanomaterials. 
Combining different nanomaterials produces nanocomposites with synergistic 
effects and exciting new properties and enhanced performances not found with 
individual nanomaterials alone [77]. Nanomaterials utilised in this dissertation, 
namely graphene, iridum oxide (IrOx) and poly(methylene blue) (PMB), are 
introduced along with their properties and preparation methods below.  
 
2.4.1 Graphene - properties and preparation methods 
 Graphene is a unique two-dimensional (2-D) carbon nanomaterial, which 
has garnered tremendous interest over the past few years. Graphene use has seen 
exponential growth in its applications related to electrochemical biosensors. A 
single layer of sp
2
-bonded carbon atoms is arranged in a honeycomb lattice [78]. 
Graphene boasts a high surface area-to-volume ratio with exceptionally high 
electron mobility and ballistic electron transport [79]. It holds the potential to 
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outperform other carbon nanomaterials such as single-walled carbon nanotubes 
(SWCNTs) and multi-walled carbon nanotubes (MWCNTs). Already, the 
advantages of graphene have been demonstrated in its excellent electrocatalytic 
activity and electrical conductivity, which are superior to that of carbon nanotubes 
(CNTs) [80, 81]. Furthermore, graphene has a wide electrochemical window and 
low charge transfer resistance as compared to graphite or GC electrodes [80, 82]. 
These advantages of graphene have been exploited for enzymatic glucose [83] and 
H2O2 [84] biosensors by achieving direct electron transfer (DET) with enzymes. In 
addition, graphene has also been applied for the electrocatalytic sensing of H2O2 
[85] and dopamine [86].     
 The properties of different forms of graphene vary according to the 
preparation method. Graphene is commonly prepared by two approaches [87]. In 
the first approach, graphene is exfoliated by mechanical cleavage from graphite or 
reduction of exfoliated graphene oxide (GO). The second approach involves 
growing graphene directly on a surface by using chemical vapour deposition 
(CVD) or epitaxial growth. Mechanical cleavage of graphite gives pristine 
graphene but suffers from low throughput and difficulty in transferring the single-
layer graphene [88].   
 Reduction of GO is the most attractive method as it is cost effective and 
suitable for mass production of graphene. GO disperses well in water and many 
other solvents and can be reduced via chemical [89], electrochemical [90], 
photochemical [91] or thermal methods [92], which offer opportunities for surface 
functionalisation of the reduced graphene oxide (rGO). rGO contains many defects 
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in the carbon lattice, has numerous reactive sites at its edges and is more 
electrochemically active than pristine graphene [93]. CVD allows large graphene 
films, doped with heteroatoms such as nitrogen or boron, to be grown on nickel or 
copper substrates [94].  
 CVD-grown graphene contains defects and impurities so its properties also 
differ from pristine graphene. Epitaxially-grown graphene is formed by the high 
temperature decomposition of silicon carbide [95]. However, these two methods 
have drawbacks of low throughput and difficulty in transferring the graphene film 
to another substrate [96]. 
  
2.4.2 Iridium oxide - properties and preparation methods 
 IrOx, a semi-conductor metal oxide, is electrochromic and displays 
Nernstian to super-Nernstian responses to pH [97]. The electrochromism of IrOx 
arises from changes in its oxidation state, from colourless in Ir(III) to blue in Ir(IV) 
[98] and this property has found applications in IrOx film-based display devices 
[99] and optical storage devices [100]. The reduction of IrOx film is H
+
-dependent, 
with anhydrous films demonstrating Nernstian responses while hydrated films 
exhibiting super-Nernstian responses to pH [97]. The Nernstian response to pH is 
described by the following equation for the Ir(IV) to Ir(III) redox transition [101],  
2𝐼𝑟𝑂2(𝑠) + 2𝐻
+(𝑎𝑞) + 2𝑒− ↔ 𝐼𝑟2𝑂3(𝑠) + 𝐻2𝑂(𝑙)  
where one electron is transferred per proton. The super-Nernstian response to pH 
can be explained by complex equilibrium shown in the following equation [102],  
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2[𝐼𝑟𝑂2 𝑂𝐻 2−𝑥 2 + 𝑥 𝐻2𝑂]
 2−𝑥 − + (3 − 2𝑥)𝐻+ + 2𝑒−
↔ [𝐼𝑟2𝑂3(𝑂𝐻)3 ∙ 3𝐻2𝑂] + 3𝐻2𝑂 
where 0.12< x <0.25 according to the degree of film hydration and gives -0.073 V 
pH
-1
 to -0.081 V pH
-1
 according to the equation [102],  
𝐸 = 𝐸𝑀,𝑀𝑂,𝐻+
0 − 2.303
𝑅𝑇
𝑛𝐹
𝑝𝐻 
The potential (E) of the metal|metal oxide electrode is the result of the equilibrium 
between the sparingly soluble oxide and its saturated solution. 𝐸𝑀,𝑀𝑂,𝐻+
0  is the 
standard potential which includes the ionisation product of water and solubility 
product of the metal oxide. 𝑅 is the gas constant (8.3144 J mol-1 K-1), 𝑇 is the 
temperature in Kelvin, 𝐹 is Faraday's constant (96485C mol-1) and 𝑛 is the number 
of electrons transferred.  
 In addition to its sensitivity to pH, its stability in aqueous solution, fast 
response time and low impedance make IrOx film an appealing nanomaterial for 
the fabrication of potentiometric pH sensors [102, 103]. The response of the film to 
pH is affected by its preparation method and resulting degree of film hydration. 
IrOx films can be prepared by electrochemical growth in aqueous H2SO4 solution 
[104], electrodeposition from a solution of iridium oxalate [99, 105], sputtered 
deposition [103] and thermal treatment [102]. The first two methods yield hydrated 
films while the latter two methods result in anhydrous films. In the first method, an 
Ir wire is placed in aqueous H2SO4 solution and oxidised by potential cycling and 
the amorphous film formed is known as anodic IrOx film (AIROF) [104]. 
Electrodeposition of IrOx is an attractive approach for microelectrode array 
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modification and it is cheaper than the first method as the Ir wire is expensive. 
AEIROF is formed by anodically electrodepositing the IrOx on the electrode by 
applying a constant current [99] or potential [105] to a solution of iridium oxalate. 
Sputtered IrOx film (SIROF) is prepared by reactive sputtering from an Ir target 
using oxygen plasma onto the electrode [103]. However, the Ir target is expensive. 
Thermal preparation of IrOx film can be done by oxidising an Ir wire by immersion 
in KNO3 melt at 420 
0
C [106] or wetting it with aqueous NaOH solution and then 
oxidising it at 800 
0
C [102]. Anhydrous IrOx films need to be wetted by soaking in 
de-ionised (DI) water for several days before use [102]. Chloride is known to form 
complexes with Ir(IV), leading to dissolution of the IrOx. This dissolution can be 
reduced by coating the IrOx with Nafion. Although Nafion does not prevent 
chloride access to the electrode, it can entrap the chloroiridate complex anions and 
decrease mass transport [102].    
 
2.4.3 Poly(methylene blue) (PMB) - properties and preparation methods 
 Phenothiazine contains a tricyclic ring aromatic with sulphur and nitrogen 
atoms and its derivatives have substituents at either the 2 and 10 or 3 and 7 
positions [107]. Methylene blue (MB
+
) is a phenothiazine derivative with 
substituents at the 3 and 7 positions (Figure 2.8a). MB
+
 is electrochromic and 
appears blue in its oxidised state, hence its name. MB
+
 can undergo a series of 
electron transfers and proton transfers depending on the pH to give leuco 
methylene blue (LMB), which is colourless (Figure 2.8b) [108, 109]. Other 
common phenothiazine derivatives such as new methylene blue, methylene green, 
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azur A, toluidine blue and thionine [110, 111] are also electroactive and water-
soluble [112]. They can be adsorbed or immobilised onto the electrode to function 
as redox mediators for enzymatic electrochemical biosensors [113-116].  
 
Figure 2.8 (a) Chemical structure of MB
+
 and (b) its electrochemical reduction. 
  
 However, these mediators tend to leach over time due to their solubility in 
water, resulting in poor biosensor performance. Electropolymerisation of a 
phenothiazine derivative yields a conductive polymer film and this improves the 
stability of the mediator and biosensor. The electropolymerisation can occur at 
physiological ranges of pH, which is important for maintaining the activity of 
enzymes. It is attractive to immobilise the enzyme together with the polymer onto 
the electrode via one-step electropolymerisation in solution [117].  
 PMB is electroactive and its electrochemical reaction is shown in Figure 2.9 
[118]. It exhibits diffusion-limited behaviour due to the rate-limiting diffusion of 
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counterions into or out of the film [119]. In addition to functioning as a redox 
mediator in glucose biosensors [117], PMB is found to improve the electrocatalytic 
oxidation of nicotinamide adenine dinucleotide (NADH) [117], ascorbic acid, 
dopamine and epinephrine [120], as well as reduction of O2 [121] and has recently 
been used to achieve the DET of glucose oxidase (GOD) [122].  
 
Figure 2.9 Electrochemical reduction of poly(MB
+
) to poly(LMB). 
 
 PMB is prepared by the electro-oxidation of MB
+
 monomers by an 
electrode in solution containing a catalyst such as SO4
2-
 [123]. At high 
overpotential, the MB
+
 monomers are irreversibly oxidised to radical cations, 
which combine as oligomeric species and precipitate, forming PMB on the 
electrode [118].  
 The growth of the film depends on six factors. First, the type of electrode 
material affects the electropolymerisation. All conditions being the same, the CV 
of electropolymerising MB
+
 on Pt foil and GC electrode was reported to be 
different [124]. Second, increased adsorption of MB
+
 at metal electrode occurred at 
higher MB
+
 concentration, and upon reduction, resulted in the formation of more 
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LMB, which has poor conductivity. Hence, the resulting film is less conductive 
than that formed with lower concentrations of MB
+
 [125]. Third, the choice of 
buffer and supporting electrolyte is important to prevent MB
+
 precipitation before 
electropolymerisation. ClO4
-
 and BF4
-
 are not used since they cause MB
+
 to 
precipitate [126]. Suitable buffers include phosphate buffered saline (PBS) [117, 
118, 123, 125] and borate buffered saline [117, 124, 126, 127] and the supporting 
electrolytes include aqueous KCl [117, 124, 126] and Na2SO4 [123, 125]. Fourth, 
the pH of the solution affects the growth rate of PMB, which was found to increase 
in basic pH [126]. Fifth, the range of potential applied affects the surface roughness 
of the PMB film [127]. Smooth films are formed when the film is not over-
oxidised. However, over-oxidation results in rough films, with MB
+
 monomers 
adsorbing onto the film. Sixth, increasing the number of CV cycles enhances the 
thickness of the film, which affects the film's capability to exchange ions during the 
redox reaction and makes it sensitive to the size, concentration and degree of 
hydration of the anions in solution [125].  
 
2.5 Development of electrochemical biosensors 
2.5.1 Nitric oxide biosensors 
 NO was named „Molecule of the Year‟ in 1992 and since then, its 
biological role as a signalling molecule has been extensively studied. It plays an 
important role in the regulation of cell function of the nervous, vascular and 
immune systems [128], such as acting as a neurotransmitter [129], modulating 
vasodilation [130] and the action of macrophages [131], respectively. It is also 
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implicated in the pathogenesis of these systems as seen in tumour angiogenesis 
[132] and Parkinson‟s disease [133]. Electrochemical sensing offers the advantages 
of simplicity and quantitative real-time detection of NO in vitro [134-139], in situ 
[140-142] and in vivo [143, 144] with excellent sensitivity through the use of 
nanomaterials and nanocomposites, as well as selectivity by using membranes such 
as Nafion which could prevent interfering species from reacting at the electrode 
[145].  
 The earliest NO sensor was a Clark type NO electrode by Shibuki in 1990, 
which detected the direct electro-oxidation of NO on the electrode surface [141]. 
The electrode comprised a Pt working electrode and Ag counter electrode inserted 
into a glass micropipette which was filled with aqueous NaCl and HCl solutions 
and sealed with a chloroprene rubber membrane [146]. However, its sensitivity was 
low and the electrode was fragile [146]. Improvements were made to this 
amperometric NO sensor by incorporating a Pt wire disk as the working electrode 
and a Ag|AgCl reference electrode within a Faraday-shielded stainless steel sleeve 
and this gave rise to the first commercial NO sensor in 1992 [147]. Meanwhile, 
surface-modified carbon fibre NO microelectrodes were explored, such as that 
reported by Malinski and Taha in 1992. Their electrode was coated with tetrakis 
porphyrin and Nafion [145], which allows the elimination of interfering species 
such as dopamine and ascorbic acid [146]. Recently, the use of nanomaterials and 
nanocomposites has tremendously enhanced the performances of NO sensors. 
These include SWCNTs/room temperature IL composite gel [134], MWCNTs 
[135] and myoglobin/MWNCTs [136] and Au nanoparticles (NPs) immobilised on 
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various substrates [137-139], which exhibit nanomolar limits of detection, high 
sensitivities above 100 nA µM
-1
 and fast response times. 
 
2.5.2 O2 biosensors 
 O2 is critical for cell survival as it functions as the final electron acceptor in 
the electron transport chain, which creates a H
+
 gradient that is needed to drive the 
oxidative phosphorylation of ATP in the mitochondria during aerobic cellular 
respiration [3]. When the cell is lacking in O2, it switches over to anaerobic cellular 
respiration. However, prolonged O2 deprivation will kill the cell and the 
measurement of dissolved O2 or O2 tension is clinically important for detecting and 
monitoring ischemia [148], particularly for patients with traumatic brain injuries 
[149].  
 The first amperometric O2 biosensor was developed by Clark in 1954, 
which came to be known as the Clark electrode [150]. It consists a Pt 
microelectrode and a Ag|AgCl reference electrode in a chamber sealed with a 
Teflon membrane and containing aqueous KCl solution. O2 in solution diffuses 
across the membrane and is electrochemically reduced at the Pt microelectrode. 
The use of nanomaterials and nanocomposites have tremendously improved the 
electrocatalytic detection of dissolved O2. Metallophthalocyanines, 
metalloporphyrins and their nanocomposites [151, 152] are popular choices for O2 
reduction despite difficulty in electropolymerising them [153], since they often 
demonstrate 4 e
-
 transfer for the reduction of dissolved O2 [151, 152]. O2 
biosensors based on these materials include layer-by-layer (LBL) iron(III) tetra-(N-
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methyl-4-pyridyl)-porphyrin (FeT4MPyP) and iron tetrasulfonated phthalocyanine 
(TeTsPc) [153], SiO2/SnO2/Mn(II) phthalocyanines [154], mesoporous 
SiO2/C/cobalt(II) phthalocyanine (Si/C/CoPc) [155] and cobalt tetrasulphonated 
phthalocyanine/ poly(L-lysine) (PLL) [156]. Anthraquinone-derivative 
functionalised MWCNTs nanowires (HOOC-2-AQ/AMWCNTs) [157], 
indigotetrasulfonate/PLL [158] and PMB-doped SiO2 NPs [121] have also been 
used as O2 biosensors. These nanocomposite-based O2 biosensors have achieved 
detection limits on the order of 10 µg L
-1
, linear ranges over a few mg L
-1
 and 
excellent sensitivities on the order of µA mg
-1
 L cm
-2
. 
 
2.5.3 pH biosensors  
 pH is an important indicator of cell metabolism. For example, H
+
 are 
formed during glycolysis and the Kreb cycle [3]. Enhanced glycolysis increases 
intracellular H
+
 concentration and the excess H
+
 are removed by the H
+
/ATPase, 
causing extracellular pH to fall [21]. Increased lactate and CO2 production by the 
cell also lead to a decrease in extracellular pH [67]. The secretion of H
+
, such as 
that by the parietal cells of the gastric glands, is important in maintaining the 
acidity of the stomach [105]. The levels of extracellular and intracellular pH are 
therefore important indicators of cellular metabolic rates [67]. The measurement of 
pH is also critical in diagnosing diseases such as gastroesophageal reflux disease 
[159] and myocardial ischemia [160].  
 The traditional pH sensor is the glass electrode [161]. A Galvanic potential 
difference arises at the glass-solution phase boundary and is a function of the 
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proton activity of the solution, allowing pH to be potentiometrically measured [70]. 
However, it suffers from slow response time, has high impedance and is 
mechanically fragile [102]. Metal|metal oxide electrodes such as the Ir|IrOx film 
electrode [102], Au|IrOx film microelectrode [105, 162, 163] and tungsten|tungsten 
oxide film nanoelectrode [164] show improved stability, fast response time and low 
impedance towards in vivo [162] and in situ pH measurements [102, 105, 163, 
164]. Notably, hydrous IrOx films exhibit super-Nernstian response of -0.073 V 
pH
-1
 to  -0.081 V pH
-1
 and therefore high sensitivity to pH [97]. Together with their 
ease of preparation through electrochemical growth or electrodeposition, hydrous 
IrOx film remains an attractive nanomaterial for potentiometric pH sensors. Other 
nanomaterials such as processible poly(aniline) [165], carboxyl group-
functionalised SWCNTs [166] and solution-gated epitaxial graphene [167] have 
also shown excellent performances for pH measurements.  
 
2.5.4 Glucose biosensors   
 Glucose is the key biomolecule involved in glycolysis, which is needed to 
drive the generation of ATP in the cell [3]. Hence, the rate of glucose uptake is 
indicative of the energy demands of the cell. Diabetic patients suffer from 
hyperglycemia and the development of glucose biosensors has been centred around 
the need for these patients to monitor their blood glucose concentration [168].  
 The first generation enzymatic glucose biosensor was proposed by Clark 
and Lyons in 1962 by entrapping a thin layer of glucose oxidase (GOD) over an O2 
electrode using a dialysis membrane, which would detected glucose levels by 
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measuring the consumption of O2. [169]. The reaction of glucose with O2 catalysed 
by GOD is as follows [170], 
𝐺𝑙𝑢𝑐𝑜𝑠𝑒 + 𝑂2
   𝐺𝑂𝐷    
     𝐺𝑙𝑢𝑐𝑜𝑛𝑜𝑙𝑎𝑐𝑡𝑜𝑛𝑒 + 𝐻2𝑂2 
The design of the glucose biosensor was improved by Updike and Hicks, who 
added a second O2 electrode as a control [171]. Guilbaurt and Lubrano developed a 
glucose biosensor based on the amperometric detection of H2O2 liberated by the 
reaction of glucose and O2 catalysed by GOD [172]. However, the sensitivity of the 
first generation glucose sensor is low due to the insulative shell of GOD, which 
impedes electron transfer from its redox centre to the electrode surface [73]. Since 
the 1990s, the use of electron mediators such as ferrocene derivatives and osmium 
compounds in second generation enzymatic glucose biosensors improved the 
transfer of electrons to the electrode and enhanced the sensitivity of these 
biosensors [73, 168]. However, mediators often leach out from the electrode over 
time.  
 Third generation enzymatic glucose biosensors no longer require electron 
mediators and instead capitalise on DET from the flavin adenine dinucleotide 
(FAD) redox centre of GOD to the electrode surface through the use of 
nanomaterials and nanocomposites with high electrical conductivity and large 
surface area-to-volume ratio. These include IL/mesoporous carbon/GOD [173], 
chemically rGO/GOD [82],  nanostructured TiO2/GOD [174], carbon decorated-
zinc oxide nanowire array/GOD [175], NiO hollow spheres/poly(3,4-
ethylenedioxythiophene)/GOD [176] and graphene/Au NPs/GOD/chitosan [177]. 
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The recent development of non-enzymatic glucose biosensors have involved the 
use of  Cu nanowires [178], PtAu-MnO2 binary nanocomposite [179], free-standing 
SWCNT film [180], Pt-Pb alloy NPs/MWCNTs [181], PtNi  NPs/graphene [182] 
and 3-D graphene/cobalt oxide [183] for the direct oxidation of glucose. These two 
classes of glucose biosensors display impressive performances with detection 
limits on the micromolar to nanomolar scale, millimolar linear ranges and 
sensitivities with an order of 10 to 100 µA mM
-1
 cm
-2
, which can be practically 
applied for the detection of glucose levels of diabetic patients in vitro.   
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3 Highly sensitive nitric oxide sensing using three-dimensional graphene/ 
ionic liquid nanocomposite† 
3.1 Abstract  A nanocomposite gel with a uniform porous structure and 
well-controlled compositions prepared by mixing 3-D graphene material with an 
IL, 1-butyl-3-methylimidazolium hexafluorophosphate, is used for NO detection. It 
shows a fast response of less than 4 seconds, an excellent sensitivity of 11.2 µA 
cm
-2 
(µmol/L)
-1
 and an extremely low detection limit of 0.75 nM with a signal-to-
noise ratio of 3 (S/N = 3), a performance superior to that of reported works based 
on CNTs and Au NPs. The high sensitivity is attributed to the large electroactive 
surface area of the graphene gel nanocomposite towards NO oxidation. The 
electrochemical behaviour of the gel nanocomposite is investigated and explained.  
 
 
 
 
___________________________________________________________________ 
† This paper is cited as reference [184]. Reprinted (adapted) with permission from 
S.R. Ng, C.X. Guo, C.M. Li., Highly sensitive nitric oxide sensing using three-
dimensional graphene/ionic liquid nanocomposite. Electroanalysis, 23(2): 442-448. 
Copyright (2011) WILEY-VCH.  
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3.2 Introduction  
 NO is a biological signalling molecule and plays an important role in the 
regulation of angiogenesis. During hypoxia, the production of NO is increased in 
the endothelial cells (ECs) (Chapter 2.1.1) [37]. It binds to cytochrome c oxidase 
(CcO) in the mitochondrion to inhibit cellular respiration to allow O2 redistribution 
within the cell and also enhances cell permeability [39, 40]. The binding of 
vascular endothelial growth factor A (VEGFA) to its receptor on the cell 
membrane triggers intracellular events which lead to increased NO production that 
stimulate the cell to proliferate and migrate in response the VEGFA gradient [54].   
 The levels of NO are critical for the proper functions of ECs while 
abnormal levels of NO are associated with diseases such as cancer [185] and 
Parkinson‟s disease [133]. Hence, the sensitive detection of NO is imperative to 
understanding its spatial and temporal release profile to elucidate both its 
physiological and pathological actions, as well as to provide a platform for 
practical applications such as clinical diagnosis. Indirect techniques such as 
fluorescent probes [186, 187], X-ray photoelectron spectroscopy [188] and reverse-
phase high performance liquid chromatography [189] have been developed to 
detect NO. However, these methods are complicated and provide little clue to the 
real-time release profile of NO. In contrast, electrochemical sensing possesses 
superior simplicity and allows the direct quantitative assessment of NO [190-195].  
 Since the first NO electrochemical sensor fabricated by Shibuki in 1990 
[196], various approaches have been explored to enhance the performances and 
robustness of the amperometric NO sensors. These include the tretrakis porphyrin 
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and Nafion-modified carbon fibre electrode [197] and a platinized platinum anode, 
which achieve nanomolar limits of detection [198]. Recently, functional 
nanomaterials have opened up a window of opportunity in electrochemistry due to 
their high surface area-to-volume ratio and tunable electron transport which 
promote efficient electron transfer [199-201]. Nanomaterials such as SWCNTs 
[202], MWCNTs [136, 203, 204], IL [205] and Au NPs [206-208] have been 
widely used in electrochemical NO sensors to enhance sensitivities and push down 
detection limits. However, the real-time detection of NO remains a challenge due 
to the trace level of the endogenous NO, and more critically, its short half-life of 5 
seconds in the presence of O2 [190, 209, 210]. Therefore, the development of NO 
sensors with high sensitivity and fast response is still greatly needed.  
 Graphene, a single layer of carbon atoms arranged in a honeycomb lattice, 
has attracted great attention lately [211, 212]. It is highly advantageous for use in 
electrochemical sensing due to its large 2-D electrochemically active surface area 
which maximises exposure to analytes and boosts sensitivity [211, 213], as well as 
its exceptionally high carrier mobility which promotes electrical conductivity [79, 
214]. Graphene also has a wide electrochemical window for detection, exhibits low 
charge transfer resistance [82, 215] and demonstrates excellent electrocatalytic 
activity [215, 216]. IL is a liquid electrolyte at temperatures below 100 
0
C which 
consists a small anion and a bulky organic cation such as imidazolium and 
pyridinium [217]. IL also possesses an intrinsically high ionic conductivity and 
electrochemical stability [202, 217-219], which makes it a candidate for 
incorporation into electrochemical sensors for the detection of gaseous analytes. 
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Very recently, IL has been extensively used as a binder to prepare carbon paste 
electrodes for broad electrochemical applications [220-225]. IL composite 
electrodes fabricated from SWCNTs [202], MWCNTs [226] and mesoporous 
carbon [218] have been developed and their electrocatalytic behaviours have been 
demonstrated. However, the use of graphene with IL for the electrochemical 
detection of NO has not been explored until now.  
 In this work, a novel carbon paste electrode was prepared by combining a 
3-D graphene material and an IL, 1-butyl-3-methylimidazolium 
hexafluorophosphate [217, 218]. The 3-D graphene material was first synthesised 
by thermal exfoliation. The IL was then grinded with the 3-D graphene material to 
form a nanocomposite gel. The morphology, composition and electrochemical 
properties of the nanocomposite were characterised. Electrochemical NO sensing 
by using the nanocomposite gel was explored.  
 
3.3 Experimental methods  
3.3.1 Materials  
 The IL, 1 butyl-3-methylimidazolium hexafluorophosphate (BMIMPF6) 
was purchased from Fluka. All other chemicals were acquired from Sigma-Aldrich 
and used without purification. 0.1 M phosphate buffered saline (PBS) (pH 7.0) was 
prepared by mixing 0.1 M NaH2PO4 (39 v%) and 0.1 M Na2HPO4 (61 v%). The DI 
water used was purified using a Millipore Milli-Q system.   
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3.3.2 Preparation of 3-D graphene material 
 Graphite powder was added into a mixture of concentrated aqueous H2SO4, 
K2S2O8 and P2O5 of weight ratio 5:1:1 and heated at 80 
0
C for 4.5 h with magnetic 
stirring. The mixture was cooled and diluted with DI water, then filtered and 
washed with DI water to remove the residual acid. The residue was dried at room 
temperature overnight and added to concentrated aqueous H2SO4 solution in an ice 
bath and stirred for 15 min. KMnO4 was gradually added and the mixture was 
heated at 35 
0
C. It was diluted with DI water in an ice bath every 2 h for 6 h. 
Aqueous H2O2 solution (30 v%) was added and the mixture was stirred for 30 min. 
The mixture was diluted with DI water, centrifuged and washed with 10 v% 
aqueous HCl solution several times. Thereafter, the mixture was washed and 
centrifuged with DI water repeatedly to remove the acid. The mixture was filtered 
and dried in vacuum at 60 
0
C to obtain graphite oxide. The graphite oxide was then 
placed in a glass bottle under vacuum conditions and heated at 150 
0
C for 45 min. 
After cooling down, a loose black powder of graphene was collected. 
 
3.3.3 Preparation of nanocomposite gel electrode 
 The process to prepare the 3-D graphene/IL nanocomposite gel is illustrated 
in Figure 3.1. 16 mg of as-prepared 3-D graphene (or MWCNTs as a comparison) 
was mixed with 1.6 mL of IL in an agate mortar for 30 min, forming a homogenous 
black paste. The same procedures were carried out to prepare the 3-D 
graphene/mineral oil nanocomposite, with the exception of using mineral oil as the 
binder. The nanocomposite was dispersed in acetonitrile and sonicated for 1 h to 
70 
 
prepare a 70% solution, which was then cast onto a glassy carbon (GC) electrode 
with an apparent surface area of 0.071 cm
2
. Subsequently, 5 µL of 10% Nafion was 
immobilised on the electrode surface to eliminate interfering species such as nitrite 
and ascorbic acid [202].   
 
Figure 3.1 Schematic representation of the fabrication of the 3-D graphene/IL 
nanocomposite as well as its photograph. 
 
3.3.4 Preparation of saturated NO in PBS  
 NO was prepared according to the procedures reported (Caution: NO is 
toxic above a concentration of 100 ppm and the preparation should be conducted in 
a fume hood) [202]. Briefly, 2 M aqueous H2SO4 solution was released drop-wise 
from a column into a round bottom flask containing saturated NaNO2 solution, 
which was stirred using a magnetic stirrer to ensure a homogenous reaction. The 
NO produced was passed sequentially through saturated aqueous KOH, 10% (w/v) 
KOH and 2.5% (w/v) KOH solutions to remove any nitrogen oxides which might 
have been produced in the reaction of H2SO4 with NaNO2. Saturated NO was 
finally collected in 0.1 M PBS. The concentration of the NO-saturated solution was 
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1.8 mM at room temperature according to the reported procedure [202]. The 
saturated NO solution was stored in a N2-protected environment for further use.  
 
3.3.5 Characterisations and electrochemical measurements 
 The morphology and microstructure of the samples were investigated by 
field emission scanning electron microscopy (FESEM, JSM-6700F, Japan). Fourier 
transform infrared (FTIR) spectra were collected by Magna-IR 500 spectrometer 
(Nicolet Instruction, USA). Electrochemical measurements were carried out using 
CHI 760B electrochemical workstation (CH Instruments Inc., Texas, USA) with a 
three-electrode system, employing a Pt coil (0.393 cm
2
), a Ag|AgCl electrode 
(0.552 cm
2
) containing saturated aqueous KCl solution (-0.039 V with respect to 
saturated calomel electrode) and the graphene/IL nanocomposite electrode as the 
counter, the reference and the working electrode respectively. The average of three 
measurements for each of the four electrodes was used to calculate the standard 
deviations. All experiments were conducted at a room temperature of 25 
0
C. 
 
3.4 Results and discussion 
3.4.1 Morphology and composition characterisation of samples  
 The morphologies of the 3-D graphene material and 3-D graphene/IL 
nanocomposite were characterised by FESEM. As seen in Figure 3.2a, the prepared 
graphene material has porous structures. Its high magnification image (Figure 3.2b) 
shows loose nanosheets packed with each other. The nanocomposite gel produced 
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by grinding 3-D graphene and IL has a uniform structure (Figure 3.2c, d). The 
uniform nanocomposite may be formed by the good interaction of 3-D graphene 
with IL through cation–π and/or π–π interactions [227], which have also been 
observed for IL with other carbon nanomaterials such as mesoporous carbon [228] 
and MWCNTs [229]. The porous structure of the nanocomposite is evident from 
the high magnification image (Figure 2d). It has recently been reported that 
nanomaterials with porous structures have fast electron transfer kinetics because 
they can be stoichiometric electron acceptors and hosts for electron-donating guest 
species [200]. In addition, the nanocomposite is stable and retains its physical gel-
like property under ambient conditions for at least three weeks.  
 
Figure 3.2 FESEM images of 3-D graphene material with (a) low and (b) high 
magnification and of 3-D graphene/IL nanocomposite with (c) low and (d) high 
magnification. 
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 The composition of the nanocomposite was examined by FTIR 
spectroscopy and the result is presented in Figure 3.3. The absorption band at 1566 
cm
-1
 is attributed to the skeletal vibration of the graphene sheets. The absorption 
band around 1725 cm
-1
 for the C=O group is observable for the 3-D graphene 
material, which are ascribed to the acid moieties on the edges of the graphene sheet 
but they should not impede the conductive properties of graphene [230]. 
Furthermore, the bands around 1412 cm
-1
 for carboxyl group and around 1232 cm
-1
 
for epoxy group totally disappear, indicating the successful preparation of graphene 
[231]. The FTIR spectrum changes greatly after mixing graphene with the IL. 
Apart from the bands of graphene, additional bands are observed. Bands at 1572 
and 1263 cm
-1
 correspond to the stretching vibrations of the C-N bonds in the 
aromatic system of imidazole, while a band at 837 cm
-1
 matches the stretching 
vibrations of P-F inside the IL. The peak at 1725 cm
-1
 for C=O is also attenuated. 
These results clearly demonstrate the successful fabrication of the 3-D graphene/IL 
nanocomposite. 
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Figure 3.3 FTIR spectra of 3-D graphene material and 3-D graphene/IL 
nanocomposite. 
 
3.4.2 Electrochemical behaviour of 3-D graphene/IL nanocomposite 
electrode  
 The electrochemical behaviour of the nanocomposite electrode was 
characterised with 10 mM of [Fe(CN)6]
3-
 in 1 M aqueous KCl solution. Figure 3.4a 
shows the CV curves obtained by varying the scan rate from 0.01 to 1.00 V s
-1
. All 
these CVs show a well-defined redox reaction with an almost unit ratio of the 
reverse-to-forward peak currents, indicating that a fast and reversible reaction 
occurred on the nanocomposite. The plots of peak current against the scan rate (v) 
and its square root (v
1/2
) are presented in Figure 3.4b. The blue line represents the 
plot of the peak current iP against the square root of the scan rate v
1/2
. At low scan 
rates below 0.40 V s
-1
, iP shows a good linear relationship with v
1/2
. However, at 
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higher scan rates, iP deviates positively from the straight line displayed at lower 
scan rates. In contrast, the red line representing the plot of the peak current iP 
against the scan rate v displays a linear relationship with v for all scan rates. The 
electrochemical behaviour of the nanocomposite electrode can be well explained 
by modelling it against the following equation [134],  
𝑖𝑝 = 𝑖𝐷 + 𝑖𝑇 = 2.69 × 10
5𝐴𝑐𝑅𝑛
3/2𝐷1/2𝑣1/2 +
𝑛2𝐹2𝑉𝑐𝑅𝑣
4𝑅𝑇
= 𝐾𝐷𝑣
1/2 + 𝐾𝑇𝑣 
 The peak current ip (A) is the sum of the peak current iD at a planar disk 
electrode and the thin-layer cell current iT formed in the inner porous 
nanocomposite. It is known that iD is proportional to v
1/2
 and iT is proportional to v 
[74]. A is the area of the electrode (cm
2
), cR is the bulk concentration of the reduced 
species (mol cm
-3
), n is the number of e
-
 transferred, DR is the diffusion coefficient 
of the reduced species (cm
2
 s
-1
), v is the scan rate (V s
-1
), F is Faraday's constant, 
(96485 C mol
-1
), V is the volume of the thin-layer cell (cm
3
), R is the gas constant 
(8.314 J mol
-1
 K
-1
) and T is the temperature (K). KD (C V
-1
) and KT (C V
-1
) are 
constants for the planar disk electrode and thin-layer cell, respectively.   
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Figure 3.4 (a) CVs of electrochemical behaviour of the 3-D graphene/IL 
nanocomposite in 10 mM of [Fe(CN)6]
3-
 in 1 M aqueous KCl using scan rates of 
0.01 V s
-1
 to 1.00 V s
-1
. (b) Plot of peak current/µA against scan rate/V s
-1
 (black 
circles) and square root of scan rate/V
0.5 
s
-0.5
 (hollow circles). 
 
 The 3-D graphene/IL nanocomposite electrode has porous structures 
(Figure 3.2c, d) and its inner porous surface area should be much larger than its 
outermost surface area. At low scan rates, the diffusion layer thickness is large 
enough to fully use up the entire inner porous electrode surface and the electrode 
behaves like a planar electrode with an expanded surface area. Thus, the linear 
relationship of iP with v
1/2
 is observed. With increasing scan rate, the diffusion 
layer path becomes shorter, but the main porous volume is still filled with 
reactant/electrolyte and this forms a thin-layer cell inside the porous 
nanocomposite [134]. This is why iP deviates from the relation of iP vs. v
1/2
 at 
higher scanning rates and eventually becomes proportional to v as shown in Figure 
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3.4, giving rise to the typical electrochemical behaviour of a thin-layer cell. This 
result is also in good agreement with the electrochemical behaviour of powder 
microelectrodes [232, 233].  
 
3.4.3 Electrocatalysis of 3-D graphene/IL nanocomposite towards sensitive 
NO detection 
 The nanocomposite was used to detect NO and the CV curves are presented 
in Figure 3.5. Curve 1 shows that the control using PBS solution without NO has 
no defined redox peak in the entire potential range, hence indicating the broad 
electrochemical window of the nanocomposite. In contrast, a large oxidation peak 
is observed on curve 2 for 0.2 mM NO in PBS. During the reaction, NO loses an 
electron and forms NO
+
, which is rapidly converted to NO2
-
 via a chemical reaction 
[134], 
 
NO – e- →NO+ 
NO
+
 + OH
-
 → HNO2 → H
+
 + NO2
- 
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Figure 3.5 CVs of 0 mM of NO in PBS using 3-D graphene/IL electrode (curve 1), 
and 0.2 mM of NO in PBS using 3-D graphene/IL (curve 2), 3-D graphene/mineral 
oil (curve 3), MWCNTs/IL (curve 4), graphite/IL (curve 5) and GC electrode 
(curve 6) (v = 0.05 V s
-1
). 
 
 The CV curves also indicate that the oxidation of NO on the electrode is a 
totally irreversible reaction since no reduction peak current (reduction peak) is 
observed from curve 2. The performance of the 3-D graphene/IL nanocomposite 
(curve 2) for NO detection was compared with that of a 3-D graphene/mineral oil 
nanocomposite (curve 3),  MWCNTs/IL nanocomposite (curve 4), graphite/IL 
nanocomposite (curve 5) and GC electrode (curve 6) as shown in Figure 3.5. The 
3-D graphene/mineral oil nanocomposite does not show any peak due to a high 
contact resistance, indicating that it is not a suitable material for the electrocatalytic 
oxidation of NO. The 3-D graphene/IL nanocomposite has a peak current density 
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of  669 µA cm
-2
, which is higher than that of the MWCNTs/IL nanocomposite (176 
µA cm
-2
), graphite/IL nanocomposite (117 µA cm
-2
) and GC electrode (64.8 µA 
cm
-2
). The higher current response of the 3-D graphene/IL nanocomposite could be 
due to its large electrochemically active surface area. In addition, NO could adsorb 
onto the IL and partition into it, leading to pre-concentration of NO on the IL.   
 The electrochemical behaviour of NO on the nanocomposite electrode was 
investigated with respect to the scan rate. It is observed that the peak current 
potential shifts positively with an increase in scan rate due to the irreversible 
reaction of NO as expected [74].   
 
Figure 3.6 Plot of peak potential/V against scan rate/V s
-1
 for CVs of 0.2 mM of 
NO in PBS using the 3-D graphene/IL nanocomposite. The inset shows the CVs.  
  
 The oxidation of NO using the nanocomposite was explored for an 
amperometric NO sensor. Figure 3.7a displays the amperometric responses 
measured at 0.8 V vs. Ag|AgCl in solutions containing different concentrations of 
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NO by successive injections of 0.8 µmol L
-1
 of NO in stirred PBS solution. The 
injected NO caused a stepped increase in oxidation current. From the steady-state 
measurements, a response time of less than 4 s was determined when the 
responding current reaches 95% of the steady-state current after injection of 0.8 
µmol L
-1
 of NO into the tested samples. The response time includes the mass 
transport time after the injection of NO to achieve a uniform solution and it should 
be actually shorter than 4 s for in situ or in vivo experiments. The calibration curve 
of the current response against the concentration of NO is presented in Figure 3.7b 
and it shows a linear range of 0.8 µM to 16 µM with a detection limit of 0.75 nM 
(S/N = 3). The sensitivity of the nanocomposite electrode calculated from the slope 
of the calibration curve is 11.2 µA cm
-2
 (µmol L
-1
)
-1
. Both the sensitivity and 
detection limit are much more superior to CNTs [136, 202, 203] and Au NPs-based 
[207, 208] NO sensing platforms listed in Table 3.1. The higher sensitivity, low 
detection limit and fast response towards NO detection can be attributed to the 
unique properties of the graphene component in the nanocomposite such as the 
large electrochemically active surface area and fast charge transfer capability. The 
notably good response of the nanocomposite towards NO is useful in solving 
problems associated with in situ NO detection such as its short half-life in the 
presence of O2 and the low concentration of NO released by endothelial cells 
(ECs). 
 Stability is critical for the sensing application of a nanocomposite. The 
stability of the nanocomposite was evaluated through its amperometric response by 
continuous testing for two hours per day in 0.1 M PBS solution. The 
nanocomposite electrode was stored under ambient conditions at room temperature 
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when it was not in use. Even after three weeks, it could still retain 95% of its initial 
amperometric response towards the same concentration of NO. This demonstrates 
the good long-term shelf-life of the nanocomposite-based NO sensor and its great 
potential for the in situ sensing of NO released by ECs during angiogenesis.  
 More work needs to be done to evaluate the biocompatibility of the  
nanocomposite electrode to ECs in order to use the electrode simultaneously as a 
growth matrix for ECs and NO biosensor to detect NO released by these cells 
during angiogenesis. The sensitivity, limit of detection and response time of the 
nanocomposite electrode for the detection of NO in the presence of endothelial 
cells and the cell culture medium need to be characterised.  
 
 
Figure 3.7 (a) Amperometric response of the 3-D graphene/IL nanocomposite over 
time following injections of 0.8 µmol L
-1
 of NO in PBS. (b) Plot of current 
response/µA against NO concentration/µmol L
-1
.  
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Table 3.1 Comparison of sensitivity and detection limit for NO of different sensors. 
Electrode materials Sensitivity based on 
apparent surface area 
of electrode/ 
µA cm
-2
(µmol/L)
-1
 
Detection limit/ 
 
nM 
Ref. 
3-D Graphene/IL 11.2 0.75 This work 
Au NPs/ITO 0.02 560 [208] 
Au NPs 4.6 27 [207] 
MWCNTs 5.8 80 [203] 
MWCNTs/Biomolecule 3.1 80 [136] 
SWCNTs/IL 2.1  100 [202] 
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3.5 Conclusion 
 3-D graphene/IL nanocomposite gel with a homogeneous, porous structure 
was prepared and characterised. The nanocomposite gel electrode has a large 
electroactive surface area and behaves as a combination of a planar disk electrode 
and a thin-layer electrochemical cell demonstrating a fast response of less than 4 s, 
a high sensitivity of 11.2 µA cm
-2
 (µmol L
-1
)
-1
 and a low detection limit of 0.75 
nM, much more superior to that of other NO sensing platforms based on CNTs and 
Au NPs. The high performance of the gel composite may be primarily attributed to 
the porous graphene material with a high specific surface area and superior 
conductivity. Furthermore, the nanocomposite-based NO sensor possesses a large 
dynamic response range and excellent stability. These results demonstrate that the 
3-D graphene/IL nanocomposite provides a novel platform for sensitive NO 
detection. 
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4 RGD-peptide functionalised graphene biomimetic live-cell sensor for real-
time detection of nitric oxide† 
4.1 Abstract 
 A free-standing biomimetic NO biosensor was fabricated by covalently 
bonding arginine-glycine-aspartic acid (RGD)-peptide on the surface of 
pyrenebutyric acid-functionalised graphene film. The resulting graphene film 
sensor comprises a well-packed layered nanostructure, in which the RGD-peptide 
component provides desired biomimetic properties for superior human umbilical 
vein endothelial cells (HUVECs) attachment and growth on the film's surface to 
allow the real-time detection of NO, an important signal yet short-lived molecule 
released by the attached cells under acetylcholine (Ach) stimulation. The film 
sensor exhibits good flexibility and stability by retaining its original response after 
45 bending/relaxing cycles and high reproducibility from its almost unchanged 
current responses after 15 repeated measurements. It possesses high sensitivity, 
good selectivity against interferences often present in biological systems and 
demonstrates real-time quantitative detection capability towards NO released by 
HUVECs. 
__________________________________________________________________ 
† This paper is cited as reference [234]. Reprinted (adapted) with permission from 
C.X. Guo, S.R. Ng, S.Y. Khoo, X.T. Zheng, C. Peng, C.M. Li. RGD-peptide 
functionalized graphene biomimetic live-cell sensor for real-time detection of nitric 
oxide molecules, ACS Nano, 6(8): 6944-6951. Copyright (2012) American 
Chemical Society.  
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4.2 Introduction 
 In the previous chapter, the 3-D graphene/IL nanocomposite was shown to 
sensitively detect NO dissolved in phosphate buffered saline (PBS) [184]. 
However, the same experimental setup is unsuitable for detecting NO released by 
endothelial cells (ECs) since the time taken for diffusion of NO from the cells to 
the electrode will be too long. The best way is to grow the cells directly on 
electrode surface so that the NO molecules can be detected almost as soon as they 
are released by the cells. Thus, the electrode surface should possess excellent 
biomimetic properties for good cell growth and adhesion, since these processes are 
very complex, highly regulated and requires ligation of specific surface receptors 
for the maintenance of cellular functions [235-237].  
 Herein, a novel approach to construct a smart functional biomimetic film 
sensor by covalently bonding RGD-peptide onto the surface of graphene to 
significantly boost cell adhesion and growth for the real-time electrochemical 
detection of NO released by HUVECs under Ach stimulation is reported. RGD-
peptide is selected because its peptide moiety mimics the cell-binding sequence of 
extracellular matrix proteins and through ligation of integrins on the outer surface 
of the cell membrane, promotes cell adhesion [238, 239].  
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4.3 Experimental methods 
4.3.1 Materials 
 All chemicals were purchased from Sigma-Aldrich, unless otherwise stated, 
and used without further purification. DI water was purified with Millipore Milli-Q 
system.  
 
4.3.2 Preparation of pyrenebutyric acid-functionalised graphene   
 Graphite oxide was prepared in the same method as described in Chapter 
3.3.2. 0.1 mg mL
-1
 graphite oxide aqueous solution was exfoliated by sonicating it 
at ambient conditions for 60 min, resulting in a dispersion of graphene oxide. 100 
mg of NaOH was added to 100 mL of the graphene oxide dispersion, followed by 
150 mg of pyrenebutyric acid to prepare the pyrenebutyric acid-functionalised 
graphene oxide dispersion. The mixture was reduced with 250 µL of hydrazine 
monohydrate at 80 
0
C overnight. The dispersion was centrifuged to yield a black 
supernatant.  
 
4.3.3 Preparation of biomimetic graphene film 
 The preparation of the biomimetic graphene film is illustrated in Figure 4.1. 
The pyrenebutyric acid-functionalised graphene dispersion was filtered through a 
cellulose acetate membrane (pore size of 0.22 µm) to produce a graphene film. The 
film was repeatedly washed with DI water and dried under vacuum. Then, the film 
was immersed in a solution of 4 mM of ethyl(dimethylaminopropyl) carbodiimide 
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(EDC) and 10 mM of N-hydroxysulfosuccinimide (NHS) for 1 h. After the 
activated film was gently rinsed with DI water, 1 mg mL
-1
 RGD-peptide solution 
was added to its surface and incubated for 2 h to yield the biomimetic graphene 
film with covalently bonded RGD-peptide, which was then rinsed with pH 7.4 PBS 
to remove the excess RGD-peptide.  
 
4.3.4 Cell culture and manipulation   
 Culture medium was prepared by mixing MCDB 131 medium, sodium 
bicarbonate, heparin, bovine brain extract (Hammond) and fetal bovine serum 
(Bio-Industries) in autoclaved DI water and filtered. HUVECs were cultured in the 
as-prepared culture medium at 37 
0
C in a humidified incubator (95% air with 5% 
CO2). To culture cells on the graphene films, HUVECs were seeded with a density 
of ~5000 cells cm
-2
 and allowed to stay at 37 
0
C in the humidified incubator (95% 
air with 5% CO2) for different durations to optimise the time for cell adhesion and 
growth. The optimised time for cell adhesion and growth was found to be 18 h.   
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Figure 4.1 Schematic illustration of preparation of the free-standing biomimetic 
film and its live-cell assay. (a) Chemical reduction of graphene oxide and 
pyrenebutyric acid functionalisation. (b) Preparation of pyrenebutyric acid- 
functionalised graphene film by filtration of the solution of pyrenebutyric acid- 
functionalised graphene. (c) Fabrication of the biomimetic graphene film by 
covalently bonding RGD-peptide onto the surface of the pyrenebutyric acid 
functionalised graphene film via EDC/NHS coupling. (d) The functional 
biomimetic graphene film as both cell adhesion and sensing matrix. 
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4.3.5 Characterisation and electrochemical measurements 
 Pyrenebutyric acid-functionalised graphene sheets were characterised by 
atomic force microscopy (AFM) (Nanoman, Veeco, Santa Barbara, CA) using the 
tapping mode. The morphologies of surface-modified graphene films were 
investigated by scanning electron microscopy (SEM) (JSM-6700F, Japan). 
Fluorescent images for fluorescein isothiocyanate mixed isomer (FITC) labelled 
graphene films were acquired with a proteomic imaging system (Perkin Elmer) 
with excitation wavelength of 494 nm and emission wavelength of 518 nm. Phase-
contrast images of cells cultured on graphene films were taken with an inverted 
microscope (Olympus IX71). Electrochemical measurements were performed in a 
three-electrode system using CHI-760D electrochemical workstation (CH 
Instruments Inc. USA) with the biomimetic graphene film (with or without cultured 
cells), Pt wire (0.473 cm
2
) and Ag|AgCl electrode (0.552 cm
2
) containing saturated 
aqueous KCl solution (-0.039V with respect to saturated calomel electrode) as 
working, counter and reference electrodes, respectively.  
 
4.3.6 Real-time detection of NO released by HUVECs   
 The setup of the device for real-time detection of NO released by HUVECs 
was the same as that for electrochemical measurement. The diameter of the low 
columniform is 2 mm and height is 20 mm. 2 mL cell culture medium was used as 
the supporting electrolyte. NO released by the cells was measured using double 
potential step chronoamperometry (DPSCA).  
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4.4 Results and discussion 
4.4.1 Characterisations of biomimetic graphene film  
 Figure 4.2a shows that the RGD-peptide functionalised graphene film has a 
free-standing structure, which comprises a well-packed layered structure (Figure 
4.2b) with a thickness of ∼8μm (Figure 4.2c). The surface of the film has a wave-
like morphology, as seen from the top-view SEM image in Figure 4.2d. The 
surface properties of different graphene-based films were investigated by reflection 
absorption infrared spectroscopy (RA-IR). Figure 4.2e shows a strong peak at 1586 
cm
-1
 for the pyrenebutyric acid-functionalised graphene film before the attachment 
of RGD-peptide (curve 1), which can be assigned to the stretch mode of a carboxyl 
group [240]. In contrast, plain graphene without pyrenebutyric acid 
functionalisation displays almost negligible peaks at 1586 cm
-1
 (not shown). These 
observations suggest the successful functionalisation of graphene with 
pyrenebutyric acid. After attachment of RGD-peptide to the pyrenebutyric acid-
functionalised graphene film, the resulting film clearly exhibits two new peaks at 
1645 and 1533 cm
-1
, corresponding to the characteristic amide I and amide II of the 
RGD-peptide [241], whereas the peak at 1586 cm
-1
 assigned to the carboxyl group 
becomes weak but is still observable (curve 2). These results indicate that RGD-
peptides are effectively covalently bonded to the pyrenebutyric acid-functionalised 
graphene film and the resulting film still has free carboxyl groups on its surface.  
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Figure 4.2 (a) Photograph of biomimetic RGD-peptide covalently bonded graphene 
film. The inset of panel (a) is an AFM image of pyrenebutyric acid-functionalised 
graphene sheets. (b) High magnification side-view, (c) low magnification side-
view and (c) top-view SEM images of the biomimetic graphene film. (d) RA-IR 
spectra of (1) pyrenebutyric acid functionalised graphene film and (2) biomimetic 
graphene film. (f) Fluorescence staining of biomimetic graphene film and the inset 
is fluorescence staining of graphene film without RGD-peptide. The scale bars 
represent 2 mm. 
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 The distribution of RGD-peptide on the film was visualised using FITC that 
is highly reactive towards primary amine groups of peptides and proteins. The 
biomimetic graphene film shows a strong signal and a uniform colour distribution, 
while the control experiment of FITC-stained graphene film without RGD-peptide 
conjugation displays a negligible fluorescence signal (Figure 4.2f), suggesting the 
uniform distribution of RGD-peptide on the graphene film. It is noted that the 
biomimetic graphene film can keep its structure intact in aqueous solution under 
mild ultrasonication, exhibiting very good mechanical strength for potential 
solution-based manipulations and testing. 
 
4.4.2 Cell adhesion on biomimetic graphene film  
 The surface property of the sensing matrix must be suitable for cell 
adhesion in order to detect biomolecules released by the attached cells in real-time.  
As shown in Figure 4.3a, HUVECs cultured on plain graphene film appear 
stretched with pseudopodia, suggesting such a film is a biocompatible platform for 
cell attachment and growth. It is known that cell adhesion and growth on a 
substrate depend not only on the surface properties of the substrate, but also on the 
type of proteins which adsorb onto its surface (from culture medium) and/or 
secreted by the cells [239], which may contribute to the observed cell adhesion and 
growth on plain graphene film. The HUVECs' attachment and growth are 
significantly improved in the presence of RGD-peptide, as clearly indicated by 
more than 2-fold increase in cell density and nearly 50% increase in cell length 
over that of plain graphene film (Figure 4.3c, d). The peptide moiety of the RGD-
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peptide mimics the cell-binding sequence of ECM proteins [238], which provides 
the graphene film its biomimetic property and greatly promotes cell adhesion and 
growth. 
 
 
Figure 4.3 Microscopy images of HUVECs cultured on (a) plain graphene film and 
(b) biomimetic graphene film. (c) The number of adhered cells and (d) the average 
cell length of HUVECs on (1) plain graphene film and (2) biomimetic graphene 
film. 
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4.4.3 Electrochemical behaviour of biomimetic graphene film  
 The biomimetic graphene film (2 cm
2
) was used to detect NO in cell culture 
medium. From Figure 4.4a, when NO was absent (curve 1), the biomimetic 
graphene exhibits only capacitive behaviour caused by its double layer over the 
entire potential range (0.0 to 1.0 V vs Ag|AgCl). In contrast, a large oxidation peak 
with peak potential at 750 mV is observed in the CV of the film in cell culture 
medium containing 10 μM of NO (curve 2), which shows good electrocatalysis 
towards the oxidation of NO. During oxidation, NO loses an electron to form NO
+
 
followed by its chemical reaction which forms NO2 as follows [134, 198], 
NO – e- →NO+ 
NO
+
 + OH
-
 → HNO2 → H
+
 + NO2
-
 
 Double potential step chronoamperometry (DPSCA) is an electrochemical 
technique which obtains the current response with high S/N ratio in a 
heterogeneous solution. Thus, changes in NO concentration can be monitored by 
using DPSCA with a double-pulse potential at a regular interval. The typical 
DPSCA recorded for NO in cell culture medium is shown in the inset of Figure 
4.4b. The current response is defined as the difference between the first potential 
(650 mV, onset potential of NO oxidation) and the second potential (750 mV, the 
peak potential of NO oxidation). The logarithmic plot of the current response vs. 
NO concentration is shown in Figure 4.4b, with two linear regions  associated with 
the increment of the NO concentration from nanomolar to micromolar. The 
detection limit is around 25 nM (S/N = 3). With HUVECs on the sensing matrix, 
the response of the biomimetic graphene films towards NO is around 1/30 of that 
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without cells and the detection limit is around 80 nM. The selectivity of the sensing 
matrix towards NO was investigated using interfering species such as nitrite, 
ascorbic acid and various ions. As seen in Figure 4.4c, the biomimetic graphene 
biofilm displays good selectivity towards NO and avoids the interferences from 
these species including nitrite, which has a similar oxidation potential to NO. The 
good selectivity of the sensing matrix may come from its retained surface carboxyl 
groups (as seen in Figure 4.2e) that bear negative charges to repel the negatively 
charged nitrite and ascorbic acid.   
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Figure 4.4 (a) CV curves of the biomimetic graphene film in culture medium in the 
absence (1) and presence (2) of 10 μM NO (v = 0.02 V s-1). (b) The logarithmic 
plot of the response current vs. NO concentration. Insets of panel B are a typical 
DPSCA used to obtain the calibration curve and the calibration curve for low 
concentration of NO. (c) Selectivity of the biomimetic graphene film for 0.3 μM 
NO against 25 µM of interfering species (NO2
-, K+, Na+, NO3
-, SO4
-, ascorbic acid).  
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4.4.4 Flexibility and reproducibility of the biomimetic graphene film  
 In order to examine the flexibility and stability of the biomimetic graphene 
film, its responses to bending and relaxing cycles were investigated. As shown in 
Figure 4.5, the film (2 cm
2
) almost retains its original current response after 45 
bending/relaxing cycles, showing excellent flexibility and stability, which is 
attributed to the good mechanical stability of graphene and strong integrity of the 
layered film. The good flexibility of the biomimetic graphene is advantageous for 
emerging applications in in vivo NO biosensor [242]. The response of the sensor is 
also highly reproducible as indicated from its stable responses after 10 
measurements. The deviation of the current responses for six biomimetic graphene 
films prepared by the same procedure is less than 7.6% (relative standard 
deviation). 
 
Figure 4.5 (a) Photographs of the relaxed and bent biomimetic graphene film. (b) 
Current responses/µA of the biofilm subjected to bending. 
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4.4.5 Real-time detection of NO released by HUVECs on the film 
 During in situ, real-time NO detection, the close proximity between the 
NO-releasing cells and the sensing matrix is a critical factor for the effective 
detection of NO, since NO has a limited diffusion distance and short half-life in the 
presence of O2. Since the HUVECs are cultured on the biomimetic graphene 
biofilm, the NO released by the cells can be efficiently detected in real-time with 
good sensitivity. The setup is shown in Figure 4.6a. Ach is selected as a model 
drug to stimulate the cells for NO release because the signalling pathway of Ach to 
NO generation by the cell is well understood. Ach binds to the cell and triggers a 
signalling cascade which activates the Ca
2+
-calmodulin complex and leads to the 
production and release of NO [243, 244]. NG-nitro-L-arginine methyl ester (L-
NAME), a NO inhibitor, was used as a model drug to inhibit the release of NO. It 
is noted that the additions of Ach (1 mM) or L-NAME (1 mM) into the cell culture 
medium does not cause any significant current change on the biomimetic graphene 
film (without cultured cells) during the electrochemical measurements, clearly 
indicating that both Ach and L-NAME are not electrochemically active over the 
range of potentials used.  
 The dynamic responses of the HUVECs cultured on the biomimetic 
graphene film towards the drugs were investigated. The DPSCA responses are 
shown in Figure 4.6b. The stimulating and inhibiting agents were added as 
indicated by the arrow. Both 1 mM and 0.5 mM Ach stimulations cause significant 
current responses which are concentration-dependent. The current response of 1 
mM Ach stimulation is more than two times than that of 0.5 mM Ach stimulation 
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after a period of 2 min as shown in Figure 4.6b, c. In contrast, no response is 
observed for the cells under the stimulation of a mixture of 1 mM Ach and 1 mM 
L-NAME, and this can be attributed to the specific inhibiting behaviour of L-
NAME towards NO release. Hence, this experiment demonstrates the capability of 
the biomimetic graphene film as a matrix for the culture of HUVECs and the real-
time, quantitative detection of NO released by these cells under Ach stimulation.  
Figure 4.6 (a) Schematic drawing showing the setup for the live-cell assay. (b) 
Real-time monitoring of NO released by the HUVECs on the biomimetic graphen 
film in cell culture medium. The drug was added at the time indicated by the arrow. 
(c) The current responses of the biomimetic graphene film with cultured HUVECs  
towards different drugs. Ach is a model drug to stimulate cell NO release and L-
NAME is a specific NO inhibitor.  
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4.5 Conclusion 
 A facile approach to construct a biomimetic NO biosensor by covalently 
bonding RGD-peptide onto the surface of pyrenebutyric acid-functionalised 
graphene film is demonstrated in this study. RGD-peptide modification gives the 
film its biomimetic characteristics for the attachment and growth of HUVECs. The 
biomimetic graphene film exhibits good flexibility and stability by retaining its 
original current response after 45 bending/relaxing cycles, and high reproducibility 
as indicated from its almost unchanged current responses after 10 repeated 
measurements, while showing high sensitivity and good selectivity towards the 
detection of NO. The attached HUVECs were stimulated by Ach and released NO, 
which was selectively detected by the film, thereby demonstrating its real-time 
quantitative detection capability for NO. This study not only reports an approach to 
fabricate a biomimetic graphene film, but also provides a powerful platform to 
build next-generation biomedical devices for live-cell assay and drug effect 
screening.  
  
101 
 
5 Iridium oxide microelectrode for the real-time physiological pH 
measurements of porcine aortic endothelial cells  
5.1 Abstract 
 Miniature pH sensors were fabricated by anodically electrodepositing 
iridium oxide films (AEIROFs) onto microelectrodes on a chip and coated with 5% 
poly(ethyleneimine) (PEI) for mechanical stability. The modified electrodes 
demonstrate super-Nernstian response to pH. The surface of the chip was coated 
with fibronectin for the cell adhesion and growth of porcine aortic endothelial cells 
(PAECs). Thrombin induces the dissolution of fibronectin, causing the pH to fall. 
Thrombin also causes extracellular acidification by PAECs and a change in cell 
morphology from stretched to round cells. The use of PD98059, a mitogen-
activated protein (MAP) kinase inhibitor, reduced extracellular acidification, 
indicating that the action of thrombin involves a MAP kinase-dependent pathway. 
The effects of thrombin on PAECs and fibronectin are significant for the activation 
of PAECs. Thrombin causes ECs to lose their anchorage on the extracellular matrix 
and acutely increases cell metabolism and cytoskeleton reorganisation, likely in 
preparation of cell proliferation and migration in thrombin-mediated angiogenesis.  
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5.2 Introduction 
 The rate of endothelial cell (EC) metabolism is influenced by many external 
stimuli. These include the pH, concentrations of dissolved O2 and glucose,  
interactions with soluble factors and the extracellular matrix. Alterations in the rate 
of EC metabolism during angiogenesis can manifest as changes in the 
concentrations of metabolic markers such as pH, lactate and CO2 (Chapter 2.2). 
Measuring extracellular pH is a good indicator of cell metabolism since an increase 
in energy metabolism increases glycolysis and CO2 production and results in 
extracellular acidification [67].   
 The measurement of pH can be achieved using potentiometric pH sensors. 
The traditional pH sensor is the glass electrode [161]. However, it has high 
impedance, suffers from slow response time and is mechanically fragile. In 
contrast, metal|metal oxide electrodes such as the Ir|IrOx film electrode [102], 
Au|IrOx film microelectrode [105, 162, 163] and tungsten|tungsten oxide film 
nanoelectrode [164] showed improved stability, fast response time and low 
impedance towards in vivo [162] and in situ pH measurements [102, 105, 163, 
164]. The potential (E) of the metal/metal oxide electrode is the result of the 
equilibrium between the sparingly soluble oxide and its saturated solution and 
changes according to the following equation [102],  
𝐸 = 𝐸𝑀,𝑀𝑂,𝐻+
0 − 2.303
𝑅𝑇
𝑛𝐹
𝑝𝐻 
where  𝐸𝑀,𝑀𝑂,𝐻+
0  is the standard potential which includes the ionisation product of 
water and solubility product of the metal oxide, 𝑅 is the gas constant (8.314 J mol-1 
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K
-1
), 𝑇 is the temperature in Kelvin, 𝐹 is Faraday's constant (96485C mol-1) and 𝑛 
is the number of electrons transferred. 
 In as early as 1947, the use of Ir as a pH electrode was proposed by Perley 
and Godshalk [245]. Between the 1970s and 1980s, investigations into the 
formation of IrOx during CV studies of an Ir electrode in acid were of great interest 
[246], particularly about their bulk and surface properties [247] and charge storage 
reactions [248]. This led to their applications as pH sensors [101, 103], 
electrocatalysts [249] and electrochromic display devices [250]. In order to exploit 
the electrochromic properties of IrOx as display devices, the electrodeposition of 
IrOx from solution onto non-metal substrates was investigated [251, 252]. The use 
of acidic sulfoiridate (III, IV) complexes to electrodeposit IrOx films from solution 
by periodic reverse current electrolysis was proposed but the solution was unstable 
[251]. Yamanaka found that the anodic electrodeposition of IrOx films from 
alkaline iridium oxalate produced smooth, lustrous films [252], and the reaction is 
given by [105], 
[𝐼𝑟(𝐶𝑂𝑂)2(𝑂𝐻)4]
2−(𝑎𝑞) + 2𝑂𝐻−(𝑎𝑞)
→ [𝐼𝑟𝑂2 𝑂𝐻)2 ∙ 2𝐻2𝑂 (𝑠) + 2𝐶𝑂2(𝑔) + 2𝑒
− 
where the oxidation of oxalate ligand forms CO2 and the hydrated IrOx is 
electrodeposited. His method has been used for the fabrication of pH sensors from 
AEIROFs on Au substrates [102, 105, 253-257].   
 The anodic electrodeposition of IrOx from iridium oxalate has been carried 
out using cyclic voltammetry [102, 247, 248, 258], applying a constant current 
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density [252, 254], constant potential [105, 259] or pulsed potential [257, 260]. The 
varying degrees of hydration depending on the electrodeposition conditions give 
rise to Nernstian to super-Nernstian response ranging from -0.061 V pH
-1
 to -0.090 
V pH
-1
 [101, 256], taking into account an error of 5 Kelvin in temperature 
measurement. The super-Nernstian behaviour can be explained by the equation 
where more than one proton is transferred per electron [101, 102, 105],    
2[𝐼𝑟𝑂2(𝑂𝐻)2−𝑥 2 + 𝑥 𝐻2𝑂]
 2−𝑥 −(𝑠) + (3 − 2𝑥)𝐻+(𝑎𝑞) + 2𝑒−
↔ [𝐼𝑟2𝑂3 𝑂𝐻)3 ∙ 3𝐻2𝑂 (𝑠) + 3𝐻2𝑂(𝑙) 
where x varies according to the degree of film hydration. The super-Nernstian 
response is desirable as it offers a higher sensitivity to pH measurements, 
particularly for studies with cells, where the changes in pH might be small.  
 Thrombin, a coagulation factor and protease, has been shown to activate 
porcine ECs during tissue inflammation [261]. Thrombin also induces an increase 
in energy metabolism in HUVECs, leading to extracellular acidification [262]. 
Fibronectin, an extracellular matrix glycoprotein, has been used for the cell culture 
of ECs on microelectrode array (MEA) chips [184, 263, 264] and prevents 
electrode biofouling with minimal effects on the catalytic property and active area 
of the electrode [265]. However, the interaction of thrombin, porcine aortic 
endothelial cells (PAECs) and fibronectin, and its acute effects on extracellular pH 
have not been studied in real-time until now. It is of interest to study this 
interaction to gain insights to thrombin-mediated angiogenesis. In this work, 
AEIROFs were miniaturised onto MEA chips, which are then coated with 5% PEI 
for mechanical stability. The surface of the chip was then coated with fibronectin 
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for the cell adhesion and growth of PAECs. The extracellular pH is measured in 
real-time to investigate the interaction of thrombin, PAECs and fibronectin.  
 
5.3 Experimental methods 
5.3.1 Chemicals 
 5 M H2SO4 and 85% H3PO4 were purchased from Fluka. 37% HCl, 70% 
HNO3 and 5 N NH4OH, KH2PO4, iridium (IV) chloride (IrCl4), 50 wt% 
poly(ethyleneimine) (PEI) (MW ~750,000) were acquired from Sigma-Aldrich. 
NaOH and KCl, as well as ethanol, were obtained from Fischer Scientific. 
Anhydrous K2CO3 was bought from Fisons Scientific Apparatus, oxalic acid 
dehydrate ((COOH)2· 2H2O) and 30 w/w% H2O2 from Analar and Decon90 from 
Decon Laboratories Limited. DI water with a resistivity of 15 MΩ cm from Purite 
was used in all experiments.  
 
5.3.2 Instruments 
 The microelectrode array (MEA) chips and chip holder were fabricated by 
Aleria Biodevices. Each chip has a Au pseudo-reference electrode, 14 Au working 
electrodes (25 µm diameter), as well as a U-shaped Au counter electrode (Figure 
5.1). The pseudo-reference electrode was not used. A leak-free Ag|AgCl reference 
electrode (IJ Cambria) (-0.052 V with respect to saturated calomel electrode) was 
used instead. A CHI 1030 electrochemical workstation (CH Instruments, Inc.) was 
employed to input the experimental parameters and acquire the data. A S20 
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SevenEasy
TM
 glass pH meter (Mettler Toledo) with temperature display was used 
to measure the pH of the phosphate buffers and the room temperature. All values of 
the sensors‟ sensitivity to pH presented here are adjusted to 25.0 0C, unless stated 
otherwise. Field emission scanning electron microscopy (FESEM) images were 
captured by a LEO 1525 Gemini. Leica microscopes were used to take the light and 
inverted light microscopy images.  
 
Figure 5.1 The MEA chip. 
 
5.3.3 Preparation of AEIROFs on MEA chip 
 The MEA chips were cleaned sequentially with Decon90, hot DI water, 
ethanol, 5 M HNO3 and DI water. The working electrodes, situated in a 1 µm 
recess, were electrochemically cleaned in 0.5 M H2SO4. AEIROF was 
electrodeposited by applying constant current density of 1.70 mA cm
-2
 for 15 min 
to the iridium oxalate solution, which was prepared according to the method 
described by Yamanaka [252]. After electrodeposition, the chips were filled with 
DI water to let the AEIROFs equilibrate overnight. The next day, the chips were 
dried with N2 and coated with 20 µL of 5% PEI to improve the mechanical stability 
of the AEIROF, since the film grew out of the recess. It is unsuitable to coat the 
chip with fibronectin directly as the presence of Cl
-
 in the cell culture medium used 
107 
 
to suspend fibronectin will react with the AEIROF to form a chloroiridate complex 
[102] and cause the film to dissolve. The chips were left to dry overnight, then 
rinsed to remove the excess PEI and filled with DI water and allowed to rehydrate 
over 1 day. pH calibrations were done for these chips from pH 4.0 to 7.7 using 
chloride-free phosphate buffers as described in the next section. The chips were 
then coated with 20 µL of 20 µg mL
-1
 fibronectin in Dulbecco‟s Modified Eagle‟s 
Medium (DMEM) and left to dry overnight in the biological safety cabinet. The 
excess fibronectin was rinsed off with Dulbecco‟s phosphate buffered saline 
(DPBS). 
 
5.3.4 pH sensor characterisation 
 CV was found to be unsuitable for characterising the AEIROFs since the 
CVs are irreproducible due to the increasing build up of the less conductive Ir(III) 
oxide with each scan. pH calibrations of the sensors were performed in phosphate 
buffers of pH 4.0, 5.0, 6.0, 7.0 and 7.7 made up of 1 M H3PO4 and 1 M NaOH at 
open circuit potential (OCP). This range of pH was investigated as the purpose of 
this project was the measurement of physiological pH of PAECs. Thus, lower and 
higher pH values were excluded from the study. The OCP vs. time was measured 
for 5 min in each solution from low to high pH using the CHI 1030. The pH 
calibration curve was obtained by plotting the OCP at the end of run against pH. 
The sensitivity is given by the slope of the best fit line and the formal potential, the 
intercept, values of which are adjusted to 25.0 
0
C. A two-point calibration using pH 
6.5 and pH 7.5 cell culture medium gassed with 5% CO2 was performed for the 
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fibronectin-coated chips before the cells were seeded. Lower pHs were not used to 
prevent the denaturation of the fibronectin.  
 
5.3.5 pH measurements of PAECs in real-time 
 PAECs of passage 8 were used. The cell culture medium contained DMEM 
supplemented with 1 mg mL
-1
 glucose, sodium bicarbonate, 5 µg mL
-1
 endothelial 
cell growth factor, 90 µg mL
-1
 heparin, 5 mM L-glutamine, 10% foetal bovine 
serum, 100 U mL
-1
 penicillin, 100 µg mL
-1
 streptomycin, 2.5 µg mL
-1
 amphotericin 
and 50 µg mL
-1
 gentamycin. The cells were cultured to confluence in T75 flasks. 
They were washed with DPBS, trypsinised and spun down at 1000 rpm for 5 min 
and finally resuspended in the cell culture medium. 30 000 cells were seeded on 
each chip and incubated at 37 
0
C and 5% CO2 overnight.  
 After 17 h, the chip was removed from the incubator and placed in the chip 
holder and continuously gassed with 5% CO2 (Figure 5.2c), which is crucial in 
getting meaningful results. HCO3
-
 acts as a buffer in the cell culture medium and 
without a constant supply of CO2, the small volume of cell culture medium will 
quickly lose its buffering capacity and the pH will rise, turning the cell culture 
medium from red to bright pink due to the presence of the phenol red indicator in 
the cell culture medium. If the pH of the cell culture medium were too high, it will 
kill the PAECs.   
 The chip was allowed to equilibrate at room temperature and the OCP was 
recorded for 30 min using CHI 1030. Reagents were added to the chip at 30 min 
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interval in the following order – two doses of 5 U mL-1 thrombin from human 
plasma (T6884) in 0.1% (w/v) bovine serum albumin (BSA), two doses of 50 µM 
PD98059 (a MAP kinase inhibitor) (Figure 2), 5.88 mM H3PO4 and 11.11 mM 
H3PO4. There was around a 5 min lag time between each step as the chip was 
disconnected from the chip holder and the 5% CO2 supply and transferred to the 
biological safety cabinet located in a different laboratory for the reagents to be 
added and for observation under the microscope. At the end of the experiment, the 
chip was rinsed thrice with cell culture medium and a two-point calibration with 
pH 6.5 and 7.5 cell culture medium was similarly performed.  
 
Figure 5.2 Experimental setup for real-time PAECs pH measurement. (a) The 
MEA chip was placed in a chip holder and (b) the leak-free Ag|AgCl reference 
electrode was positioned into the well of the chip. (c) 5% CO2 was blown across 
the top of the chip through a hole in the rubber tubing. The chip holder was 
connected to the CHI 1030 electrochemical workstation.   
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5.4 Results and discussion 
5.4.1 FESEM characterisation of AEIROF coated with PEI and fibronectin 
 Figure 5.3 shows a FESEM image of the Au|AEIROF microelectrode after 
the surface of the chip was coated with 5% PEI, followed by 20 µg mL
-1
 
fibronectin. The PEI coating cannot be observed in this case as the fibronectin 
coating is thick and forms patches on the silicon nitride surface of the chip. 
Fibronectin at high magnification appears as tightly packed clusters with a 
cobblestone morphology as seen in Figure 5.4. In contrast, PEI on silicon nitride 
consists tiny particles which are loosely packed (Figure 5.5). The difference in 
surface morphology in addition to integrin ligation may explain why PAECS did 
not attach onto 5% PEI alone but did so in the presence of fibronectin.  
 
Figure 5.3 FESEM image of Au|AEIROF microelectrode coated with PEI and 
fibronectin. 
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Figure 5.4 FESEM image of 20 µg mL
-1
 fibronectin coating on silicon nitride chip 
surface. 
 
 
 
 
 
 
 
Figure 5.5 FESEM image of 5% PEI coating on silicon nitride chip surface. 
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5.4.2 Electrochemical characterisation of PEI-coated AEIROFs 
 The super-Nernstian response to pH is observed for the PEI-coated 
AEIROFs ranging from -0.063 V pH
-1
 to -0.077 V pH
-1
, with an average of -0.069 
± 0.006 V pH
-1
 (n=5). The formal potential ranged from 0.540 V to 0.661 V, with 
an average of 0.585 ± 0.050 V. Calibration curves with good linear response (R
2 
> 
0.980) were obtained on the 2
nd
 or 3
rd
 day of calibration over the dynamic range of 
pH 4.0 to 7.7. The average t95% (n=5) are 0.3 s for pH 4.0, 19.4 s for pH 5.0, 49.6 s 
for pH 6.0, 102.4 s for pH 7.0 and 190.2 s for pH 7.7. It is possible that at lower 
pH, reduction of Ir(IV) oxide causes the build-up of the less conductive Ir(III) 
oxide, resulting in slower charge transfer during the oxidation process at an 
alkaline pH. 
 
5.4.3 Light microscopy images of control chip and chip with PAECs before 
and after cell experiments 
 Both the control chip and the chip with PAECs were coated with 5% PEI 
and 20 µg mL
-1
 fibronectin. Figures 5.6 shows the images for the control chip and 
Figures 5.7 the chip seeded with 30 000 PAECs.  
 In Figure 5.6a, the surface of the control chip appears dotted with clear 
round particles, which are likely fibronectin. After the experiment, long clear 
particles are observed instead (Figure 5.6b), which might indicate a change in the 
fibronectin structure during the course of the experiment. When the chip was 
reused and seeded with PAECs, the cells failed to attach, suggesting that the 
fibronectin had been denatured or lost from the chip. However, the dark blue 
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AEIROF was present on the control chip both before (Figure 5.6c) and after 
(Figure 5.6d) the control experiment.  
 Figure 5.7a shows the chip seeded with 30 000 PAECs and a higher 
magnification image (Figure 5.7c) confirms that the PAECs were healthy with their 
characteristic stretched, polygonal morphology at sub-confluent levels. However, 
after the first addition of thrombin, the PAECs were observed to become round and 
did not recover after the addition of PD98059 to inhibit the action of thrombin as 
seen in Figure 5.7d. Similarly, the AEIROF was visible on the chip before (Figure 
5.7d) and after (Figure 5.7f) the PAECs experiment.      
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Figure 5.6 Light microscopy images (40X) of the control chip without PAECs (a) 
after removing from the incubator and (b) after the experiment. Inverted light 
microscopy images (67X) of control chip without PAECs (c) after removing from 
the incubator and (d) after the experiment. Electrode with PEI-coated AEIROF 
circled in red.  
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Figure 5.7 Light microscopy images (40X) of chip with PAECs (a) after removing 
from the incubator and (b) after the second dose of PD98059. Light microscopy 
images (100X) of showing morphology of PAECs on chip (c) after removing from 
the incubator and (d) after the second dose of PD98059. Inverted light microscopy 
images (67X) of chip with PAECs (e) after removing from the incubator and (f) 
after the experiment. Electrode with PEI-coated AEIROF circled in red.  
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5.4.4 Effect of fibronectin coating on pH responses of sensors in cell culture 
medium 
 The preliminary data acquired for the control experiment and PAECs 
experiment are presented in Figure 5.8a and Figure 5.8b, respectively. Curve 
smoothing was carried out using a Savitzky Golay filter with second order 
polynomial fitting with 301 points for each of the 30 min run and 51 points for the 
5 min calibration runs. While the data has been presented in a continuous time 
format to facilitate visualisation and comparison of results, there is an 
approximately 5 min lag time in between each step and the first two-point 
calibration was performed a day after the fibronectin had been coated. The chip 
was also disconnected from the 5% CO2 supply for the reagents to be added, during 
which the cell culture medium would be susceptible to losing some of its buffering 
capacity. All values for sensitivity reported here are corrected to 25.0 
0
C. 
 Prior to coating with fibronectin, the PEI-coated AEIROF control chip has a 
sensitivity of -0.073 V pH
-1
 and formal potential of 0.548 V in phosphate buffer. 
After coating with fibronectin, the control chip gives a sensitivity of -0.061 V pH
-1
 
and formal potential of 0.847 V when calibrated in pH 6.5 and 7.5 cell culture 
medium. The other chip to be seeded with PAECs has a sensitivity of                       
-0.068 V pH
-1
 and formal potential of 0.540 V before coating with fibronectin. 
With fibronectin, it has a sensitivity of -0.066 V pH
-1
 and formal potential of 0.649 
V. A paired two tailed t-test (α = 0.05) for the sensitivity gives t = 1.25, which lies 
within -12.71 ≤ t ≤ 12.71, so there is no significant difference in the mean 
sensitivity before and after coating with fibronectin. The paired two-tailed t-test (α 
117 
 
= 0.05) for the formal potential gives t = 2.15, which lies within -12.71 ≤ t ≤ 12.71, 
so there is no significant difference in the mean formal potential before and after 
coating with fibronectin. The changes in sensitivity and formal potential to each 
chip could be due to the fibronectin, adsorption of proteins in the cell culture 
medium onto the film or that insufficient time has passed for the rehydration of the 
AEIROFs since coating the chip with fibronectin requires drying the chip.  
 
5.4.5 Real-time measurements of extracellular pH 
 Following incubation overnight, both the control chip and chip with PAECs 
show a large drop of around 0.25 V and 0.30 V in OCP relative to the calibration 
value for pH 7.5,  respectively. An earlier control experiment using the glass pH 
meter to measure the pH of cell culture medium without cells before and after it 
was placed in incubator overnight showed that the pH of the cell culture remained 
at 7.62. While looking at the data alone suggests that the pH had risen to pH 12, the 
colour of the cell culture medium containing phenol red indicator still appeared red 
and had neither turned bright pink nor yellow. Therefore, the pH must still be 
above 6.8 and below 8.2. Furthermore, the PAECs look healthy from the light 
microscopy images (Figures 5.7a, c) and they would otherwise have died and 
rounded up or detached if the pH had fallen drastically. This suggests that 
incubation process, possibly the heat, had modified the ratio of Ir(III) oxide to 
Ir(IV) oxide, resulting in a fall in formal potential, and the OCP measured 
immediately after removing the chip from the incubator was much lower than 
expected.    
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(a) 
(b) 
Figure 5.8 OCP/V vs. time/ks measurements of the addition of reagents to (a) 
control chip and (b) chip with PAECs. Measurements were done at an average 
room temperature of 22.0 
0
C and gassed with 5% CO2.  
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 In the control experiment shown in Figure 5.8a, the addition of 5 UmL
-1
 
human plasma thrombin introduces a rise in OCP of 0.113V (or a decrease of ~2 
pH units) at the end of 30 min. The 0.1% (w/v) BSA used to suspend the thrombin 
was pH 5.30, which could have a minor contribution towards increasing the OCP. 
The bulk of the decrease in pH is thought to have come from the dissolution of 
fibronectin into the solution following exposure to thrombin. Galdal et al. reported 
that 2 NIH U mL
-1
 bovine thrombin induced the loss of extracellular fibronectin 
fibrils from HUVECs in 30 min [266]. Furthermore, when the control chip was 
reused for the PAECs experiment, the PAECs surprisingly did not attach and 
appeared round, suggesting that the fibronectin had been denatured or lost during 
the control experiment.  
 A second dose of thrombin did not appear to have an appreciable effect on 
changing the OCP on the control chip. The two doses of PD98059 also did not 
change the OCP much with an average change of ± 0.018 V, which made it ideal 
for studying any effects the inhibitor would have on the PAECs.  
 The concentrations of the aqueous H3PO4 solution added after the two 
doses of PD98059 are carefully chosen to be within the buffering capacity of the 
cell culture medium and also to prevent further denaturation of the fibronectin. The 
addition of the acid would demonstrate that had the buffering capacity of the cell 
culture medium been exceeded due to the action of the reagents, an obvious change 
in the OCP should have been recorded. The addition of 5.88 mM H3PO4 causes the 
OCP to fall by 0.031V (or increase by ~0.5 pH unit) instead of increasing the OCP. 
This could be due to the H
+
 combining with the HCO3
-
 in the cell culture medium 
120 
 
to form CO2 and hence adding to the buffer capacity of the solution. Upon giving 
11.1 mM H3PO4, a very steady OCP is observed, perhaps indicating that the HCO3
-
/CO2 equilibrium has been re-established. The two-point calibration after the 
control experiment shows that the super-Nernstian performance of the sensor is 
retained with a sensitivity of -0.080 V pH
-1
 and formal potential of 0.658V, which 
confirms that the OCP measurements are valid.  
 As seen in Figure 5.8b for the chip with PAECs, the first dose of thrombin 
induces rapid extracellular acidification of PAECs as expected [262]. The local pH 
decreased by close to 7 pH units within minutes and 2 pH units can be attributed to 
the dissolution of fibronectin. Therefore, there is a net drop in 5 pH units due the 
action of 5 U mL
-1
 thrombin on the cells. This is followed by a fast, steady decline 
in OCP, which might be associated with a reduction in extracellular acidification as 
the PAEC morphology changed from a polygonal phenotype to a contracted 
phenotype by the end of 30 min. Such a change in cell shape had been reported by 
Galdal et al. after they exposed confluent monolayer cultures of human umbilical 
vein endothelial cells (HUVECs) to 0.5 NIH U mL
-1
 human α-thrombin for 30 min 
[267]. They also found that thrombin altered the HUVEC integrity and the cell 
membrane appeared to be more permeable [267]. The increase in membrane 
permeability could be due to the rapid disassembly of claudin-5 from the tight 
junctions of endothelial cells under thrombin stimulation as reported by Kondo et 
al. [268]. Clearly, more in depth studies would be required to understand the 
mechanism of thrombin on both the change in cell morphology and extracellular 
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acidification and how the two are related. The sudden rapid change in pH could 
also shock the cells and result in cell death. 
 During the second dose of thrombin, the PAECs give a more steady OCP 
than during the first dose and the steady decline in OCP was not observed, 
probably because the rate of change of PAECs from the polygonal phenotype to 
contracted phenotype has reached its maximum and was quite stable. The pH is 
still about 4.6 units lower than the pH value after equilibration to ambient 
conditions. Taking into account the 2 pH units from the dissolution of fibronectin, 
10 UmL
-1
 thrombin continues to have a net effect of lowering the pH by 2.6 units.  
 The addition of 50 µM PD98059 caused a reduction in extracellular 
acidification [262], resulting in a decrease in the OCP as expected and the pH falls 
by about 0.8 pH unit. A second dose of PD98059 causes the OCP to fall further by 
almost 1 pH unit as the extracellular acidification was further reduced. However, 
the PD98059 did not cause the cells to recover to their polygonal phenotype for the 
duration at which the experiment was performed.   
 When 5.88 mM H3PO4 was added, a gradual increase in OCP 
corresponding to a decrease in 1 pH unit is observed. This clearly shows that the 
buffer capacity of the cell culture medium had been depleted during the previous 
steps. Further addition of H3PO4 to a final concentration of 11.11 mM induces an 
initial decrease in pH by 0.8 unit but the pH rose by the same amount at the end of 
30 min. This could possibly be the same phenomenon as in the control experiment 
when the addition of acid appears to be increasing the buffer capacity of the chip. 
The two-point calibration after the experiment shows that the sensor preserved its 
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super-Nernstian response to pH with a sensitivity of -0.075 V pH
-1
 and formal 
potential of 0.748V.  
 In both the control chip and chip with PAECs, the two-point calibration in 
cell culture medium after the experiment shows that the super-Nernstian 
sensitivities of the AEIROFs are retained. A paired two tailed t-test (α = 0.05) for 
the sensitivity gives t = -1.06, which lies within -12.71 ≤ t ≤ 12.71, so there is no 
significant difference in the mean sensitivity before incubation (calibration in cell 
culture medium for fibronectin-coated chips) and after the experiment. The paired 
two tailed t-test (α = 0.05) for the formal potential gives t = -0.31, which lies within 
-12.71 ≤ t ≤ 12.71, so there is no difference in the mean formal potential before 
incubation (calibration in cell culture medium for fibronectin-coated chips) and 
after the experiment. In addition, the presence of the AEIROFs were confirmed 
from the inverted light microscopy images taken after the experiment. Thus, the 
changes in pH measured from the OCP are valid.  
 However, the formal potential is different from the expected value 
assuming that the pH should be ~pH 7.6 at the end of the equilibration run. This 
could be due to a change in the ratio of the Ir(III) oxide to Ir(IV) oxide during the 
course of the experiment and insufficient time had passed to allow for the species 
to equilibrate. Hence, while the sensors cannot be used to accurately determine the 
pH of the solution without knowing the values to expect, their high sensitivities are 
extremely advantageous to measuring acute pH changes in real-time.  
 The interaction of thrombin, PAECs and fibronectin and its acute effects on 
extracellular pH are studied in this work. Thrombin induces the dissolution of 
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fibronectin and PAECs exhibits a change in cell morphology as it loses its 
attachment to fibronectin [266]. Thrombin also causes acute extracellular 
acidification of the PAECs through a MAP kinase-dependent pathway [262], which 
was partially inhibited by the addition of the PD98059 inhibitor. The increase in 
extracellular acidification may be attributed to increased glycolysis and Na
+
/H
+
 
exchange by the PAECs [262], due to an increase in cell metabolism. Such effects 
of thrombin on PAECs and fibronectin are significant for the activation of PAECs. 
Thrombin causes ECs to detach from the extracellular matrix and increases their 
metabolism and causes cytoskeleton reorganisation, likely in preparation for 
proliferation and migration in thrombin-mediated angiogenesis [262].  
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5.5 Conclusion 
 AEIROFs were miniaturised onto MEA chips and coated with 5% PEI and 
the resulting film demonstrated super-Nernstian responses to pH. The chip was 
then coated with fibronectin for the on-chip culture of PAECs. The changes in 
extracellular pH of the PAECs exposed to fibronectin were investigated in real-
time. Thrombin dissolves fibronectin and causes the pH to fall. Thrombin also 
induces the acute extracellular acidification by the PAECs, which likely indicates 
an increase in cell metabolism. The morphology of the cells also changed from a 
stretched phenotype to a round phenotype. PD98059, the MAP kinase inhibitor, 
reduces extracellular acidification. This shows that the effect of thrombin on 
extracellular acidification of the cells requires a MAP kinase-dependent pathway. 
This effects of thrombin on PAECs and fibronectin is significant for the activation 
of PAECs. Thrombin causes ECs to lose their anchorage on the extracellular matrix 
and acutely increases cell metabolism and cytoskeleton reorganisation to prepare 
for cell proliferation and migration in thrombin-mediated angiogenesis.  
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6 O2 and glucose biosensors based on a novel electropolymerised redox 
polymer  
6.1 Abstract 
 An O2 biosensor and a glucose biosensor based on a novel 
electropolymerised redox polymer film are developed. To prepare the O2 biosensor, 
20 mM methylene blue (MB
+
) and 1 mM pyrrole were mixed together as a 
precursor solution to electrodeposit a film on a Au electrode by cyclic voltammetry 
(CV). The glucose biosensor was electrochemically fabricated in the solution 
prepared by adding 4 mg mL
-1
 glucose oxidase (GOD) to the precursor solution 
described above. The presence of pyrrole prevents the formation of MB
+
 
monomers in the polymer film, giving rise to the electrochemical, followed by 
catalytic (EC') mechanism of the film and enhances the stability of the polymer 
film. The O2 biosensor (Au|PMB-PPy) has a superior sensitivity of 244 µA mM
-1
 
cm
-2
, linear range of 0.014 mM to 0.254 mM and detection limit of 0.597 µM (S/N 
= 3) for dissolved O2. Notably, it is pH-insensitive in both N2-purged and 
atmospheric (atm) O2 PBS from pH 4 to 8 and is promising for use in physiological 
conditions where pH fluctuations are expected. The glucose biosensor (Au|PMB-
PPy-GOD) exhibits direct electron transfer (DET) in N2-purged PBS and glucose 
solutions. In atm O2, it possesses a sensitivity of 6.06 µA mM
-1
 cm
-2
 in the linear 
range of 0.25 mM to 1.49 mM glucose with a detection limit of 29.7 µM glucose 
(S/N = 3). It is pH-insensitive in N2-purged PBS from pH 6 to 8 and atm O2 PBS 
from pH 4 to 8, highlighting its potential for use in physiological pH conditions.   
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6.2 Introduction  
 The levels of O2 and glucose play key roles in regulating angiogenesis as 
explained in Chapters 2.1 and 2.2. Protein hydroxylase domain containing protein 2 
(PHD-2) is inhibited during hypoxia and in the presence of lactate, a by-product of 
glucose metabolism [12]. This in turn allows the hypoxia inducible factors (HIFs) 
to enter the nucleus and NO and vascular endothelial growth factor A (VEGFA), 
which upregulate angiogenesis, are produced [36, 37]. Hence, the real-time 
detection of extracellular levels of dissolved O2 and glucose of endothelial cells 
(ECs) are important for the study of angiogenesis. 
 The miniaturisation of electrodes onto lab-on-a-chip devices is an attractive 
approach for the real-time detection of biomolecules uptaken or released by cells or 
tissues on the chip. An electrochemical cytosensor
TM
 microphysiometer capable of 
measuring extracellular dissolved O2, glucose, lactate and acidification rate using 
modified Pt microelectrodes has been reported [269]. Dissolved O2 was measured 
by electrochemical reduction a Nafion-coated Pt microelectrode, glucose and 
lactate by oxidising H2O2 produced by the corresponding first generation 
enzymatic biosensors, and acidification rate by potentiometry. However, there have 
been limited examples of nanomaterials-based electrochemical microphysiometer 
for the simultaneous detection of metabolic markers. The primary difficulty lies in 
designing an electrode modification method which allows each microelectrode on 
the chip to be individually modified. This can be overcome through the use of 
electrochemical growth techniques such as electrodeposition or 
electropolymerisation.  
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 In this work, O2 and glucose biosensors were prepared by one-step 
electropolymerisation so that they can be independently miniaturised onto lab-on-
a-chip devices in future to investigate the effects on which the degree of hypoxia 
has on the glucose metabolism of ECs. Amperometric O2 biosensors based on 
direct electrochemical reduction of O2 suffer from the interference of solution pH, 
since its reaction involves H
+
 and makes it pH-sensitive. This problem was 
addressed by indirectly detecting dissolved O2 by coupling it to an electrochemical 
reaction that is not pH-sensitive.  
 The second challenge is that the glucose biosensor must be able to operate 
under hypoxia for our purposes. First generation enzymatic biosensors require O2 
to function while second generation enzymatic biosensors suffer from the leaching 
of mediators [170]. In the third generation glucose biosensors, nanomaterials or 
nanocomposites enable the direct electron transfer (DET) of the flavine adenine 
dinucleotide (FAD) active centre of the glucose oxidase (GOD) [176], allowing the 
reagentless glucose biosensor to operate without O2, making them the best 
approach to the problem. 
 So far, there have been few examples of one-step electropolymerised third 
generation glucose biosensors. Many third generation glucose biosensors require  
multiple preparation steps and GOD is often adsorbed [83, 173, 175, 176, 270] 
onto the nanomaterials or nanocomposites, but such methods are unfeasible for 
modifying individual microelectrodes on a chip. Polypyrrole (PPy) is a popular 
choice for the one-step electropolymerisation with GOD for glucose biosensors 
since it forms a conductive polymer at physiological pH and preserves the activity 
128 
 
of GOD [271, 272]. However, PPy has poor stability in aqueous solution due to 
solution attack, which results in the loss of electronic communication between the 
PPy molecules [273]. Phenothiazines such as methylene blue (MB
+
) have been 
used as soluble mediators in enzymatic biosensors. Interestingly, 
electropolymerisation of MB
+
 within physiological pH yield conductive 
poly(methylene blue) (PMB), making it attractive for one-step 
electropolymerisation with GOD. Recently, two step-electropolymerisation was 
used to prepare PMB-doped silica nanocomposites on a glassy carbon electrode, 
which showed electrocatalytic activity towards the reduction of dissolved O2 [121] 
and GOD cast onto the PMB-doped silica nanocomposites showed DET [122], 
highlighting the feasibility of using PMB for the detection of O2 and for making a 
third generation glucose biosensor.   
 It is found that PMB electropolymerised on a Au electrode (Au|PMB) has 
poor stability (Figure S6), perhaps due to the bulky size of the MB
+
 monomer, 
which makes the formation of continuous polymer chains difficult. To overcome 
this problem, pyrrole was introduced to stabilise the polymer formed. The 
synergistic effects of PMB with PPy are described in this work.  
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Figure S6 CV of Au|PMB in atm O2 PBS on the 1st day (red) and 9th day (blue) (v 
= 0.050 V s
-1
).  
 
6.3 Experimental methods 
6.3.1 Chemicals 
 MB
+
, pyrrole, GOD from Aspergillus niger, β-D-glucose, H2SO4,  Na2SO4, 
KOH and phosphate buffered saline (PBS) were purchased from Sigma-Aldrich. 
Na2HPO4 and KH2PO4 were obtained from Fisher Scientific. HCl was acquired 
from Analar and ethanol from Aik Moh Chemicals. DI water was used for all 
experiments. Pyrrole was distilled and stored under N2-protection in the dark at      
4 
0
C when not in use. PBS of acidic pH was prepared by adding HCl and that of 
alkaline pH was made by adding KOH. 0.01M PBS (pH 7.4) was bubbled with N2 
or O2 at least 20 min for experiments in N2-purged PBS and O2-saturated PBS, 
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respectively. Glucose solutions were prepared in PBS at least one day in advance to 
allow time for the mutarotation of the glucose molecules. 
 
6.3.2 Instruments 
 A CHI 660D electrochemical workstation (CH Instruments, Inc.) was used. 
A three-electrode setup was employed for all electrochemical experiments with a 
Ag|AgCl reference electrode (0.552 cm
2
) containing saturated aqueous KCl 
solution (-0.039 V with respect to saturated calomel electrode), Au (2 mm 
diameter) working electrode and Pt coil (0.393 cm
2
) as the counter electrode. A 
Hanna pH meter (Sigma-Aldrich) was used to measure the pH of the solutions. For 
FESEM imaging, the polymer films were grown on Au electrodes prepared by 
physical vapour deposition on indium tin oxide glass and imaged using Jeol JSM-
6700F FESEM.  
 
6.3.3 Preparation of dissolved O2 and glucose biosensors 
 The Au electrode was polished with 0.05 µm alumina slurry, sonicated in 
ethanol, followed by DI water. It was then electrochemically cleaned in 0.5 M 
H2SO4 by CV (-0.5 V to 1.7 V, 0.5 V s
-1
, 25 cycles), held at -0.5 V for 5 min to 
reduce any oxide formed, then rinsed with DI water and dried by N2. A pH 7.3 
buffer solution containing 0.1 M Na2HPO4, 0.025 M KH2PO4 and 0.1 M Na2SO4 
was prepared. Fresh 20 mM MB
+
 and 1 mM pyrrole were added to the buffer 
solution as the precursor to fabricate the O2 biosensor, and an additional 4 mg mL
-1 
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GOD was added for the construction of the glucose biosensor. SO4
2-
 is a catalyst 
for the electropolymerisation of MB
+
 and the electropolymerisation is more 
efficient at alkaline pH [119]. The electrode was quickly immersed into the 
precursor solution and CV (-0.6 V to 1.2 V, 0.1 V s
-1
, 50 cycles) was used to 
electropolymerise the monomers without or with GOD onto the surface of the 
electrode, forming Au|PMB-PPy and Au|PMB-PPy-GOD as the O2 and glucose 
biosensors, respectively. After electropolymerisation, the electrode was soaked in 
0.01 M PBS several times to remove the excess MB
+
. This was followed by 
potential cycling in PBS (-0.5 V to 0.2 V, 0.1 V s
-1
, 10 cycles) for anion exchange 
and the electrode was stored in PBS at 4 
0
C overnight before use.  
   
6.4 Results and discussion 
6.4.1 FESEM characterisation of O2 biosensor 
 Figure 6.1 shows the FESEM images of PMB-PPy. The PMB-PPy appears 
flat and is dotted with spots (Figure 6.1a), which are likely salt crystals and small 
clumps of polymer as seen in the high magnification image (Figure 6.1b). The 
generally flat surface of the film implies that it is not over-oxidised, since rough 
films are formed when the film is over-oxidised [127].  
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Figure 6.1 (a) Low magnification FESEM image (2200X) and (b) high 
magnification FESEM image (35 000X) of PMB-PPy.  
 
6.4.2 Electrochemical characterisation of O2 biosensor in N2-purged PBS 
 Au|PMB-PPy was characterised using different scan rates by CV in N2-
purged PBS. As seen in Figure 6.2, a pair of redox peaks are observed around         
-0.34 V and -0.26 V. The Au|PMB-PPy demonstrates diffusion-limited behaviour 
since the gradient of both curves in Figure 6.3 are close to 0.5, which implies that 
the cathodic (ip,c) and anodic (ip,a) peak currents scale almost proportionally with 
the square root of scan rate (v
0.5
). This behaviour is in agreement with that reported 
by Barsan et al. for PMB [119], who proposed that the diffusion of counterions into 
or out of the polymer film is rate-limiting. From Figure 6.4, the anodic peak 
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potential (Ep,a) remains constant with different v and this is characteristic of a 
reversible reaction, while the cathodic peak potential (Ep,c) shifts negatively with 
increasing v. The formal potential (E
0
') was estimated by 
𝐸𝑝 ,𝑎 +𝐸𝑝 ,𝑐
2
 and the peak 
separation (∆Ep) was calculated by (Ep,a - Ep,c) and given in Table 6.1. From Table 
6.1, ∆Ep suggests that the reaction is a highly reversible 1 e
-
 transfer at 0.025 V s
-1
, 
but becomes quasi-reversible at higher v. 
 
 
Figure 6.2 CV of Au|PMB-PPy in N2-purged PBS with different scan rates. 
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Figure 6.3 Plot of log(-ip,c)/A against log v/V s
-1
 (red circles) and plot of log(ip,a)/A 
against log v/V s
-1
 (blue squares) for Au|PMB-PPy in N2-purged PBS.  
 
 
Figure 6.4 Plot of Ep,c/V (red circles) and Ep,a/V (blue squares) against v/V s
-1
 for 
Au|PMB-PPy in N2-purged PBS. 
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Table 6.1 Values of formal potential (E
0
')/V and peak separation (∆Ep)/V against 
scan rate/V s
-1
 for Au|PMB-PPy in N2-purged PBS with different scan rates.
 
 
Scan rate/ V s
-1
 E
0
'/ V ∆Ep/ V 
0.005 -0.259 0.047 
0.010 -0.260 0.049 
0.025 -0.264 0.059 
0.050 -0.269 0.075 
0.075 -0.270 0.079 
0.100 -0.274 0.082 
0.200 -0.280 0.096 
0.300 -0.285 0.097 
0.400 -0.286 0.105 
0.500 -0.288 0.106 
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6.4.3 Effect of pH on O2 biosensor in N2-purged PBS 
 Since it is of interest to utilise the O2 biosensor under physiological 
conditions, the effect of pH on the Au|PMB-PPy is investigated (Figure 6.5). As 
seen in Table 6.2, ∆Ep increases as pH decreases. The value of ∆Ep at pH 8 implies 
a 1 e
-
 transfer reaction, which becomes increasingly sluggish as pH falls and it 
appears kinetically more difficult to reoxidise the polymer. The loss of e
-
 needs to 
be accompanied by the expulsion of positively charged counterions to maintain 
charge neutrality within the film. Since there are more H
+
 in the solution as pH 
falls, it becomes harder for these counterions to be expelled. This, however, does 
not affect the amperometric detection of dissolved O2 using the Au|PMB-PPy since 
a constant cathodic potential will be applied. An extra cathodic peak is observed 
around -0.10 V in pH 4. This may be due to Cl
-
 de-doping from the polymer film 
since the largest amount of HCl was added to prepare the pH 4 PBS.    
 The negligible effect of pH on PMB-PPy (Figure 6.5) is interesting as it 
differs from the expected pH-dependent electrochemistry of PMB alone (Figure 
6.7) [118], where parallels can be drawn to that of MB
+
 (Figure 6.8) [108, 109]. 
Dimers of MB
+
 form at the N with the methyl groups, with longer chains giving 
rise to PMB (Figure 6.6) [119]. The N at the centre of the ring has a lone-pair and 
can accept a H
+
. Hence, the electrochemical reduction of poly(MB
+
) to poly(LMB) 
is expected to be pH-dependent (Figure 6.7). However, the reduction of PMB-PPy 
appears to be pH-independent (Figure 6.5). It could be that during 
electropolymerisation, pyrrole reacts with MB
+
 and binds to the N in the centre of 
the ring and the resulting PMB-PPy becomes unable to accept H
+
. The following 
equation is proposed for the electrochemistry of Au|PMB-PPy in N2-purged PBS,      
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 𝑃𝑀𝐵 − 𝑃𝑃𝑦  𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑 + 𝑒− → [𝑃𝑀𝐵 − 𝑃𝑃𝑦] 𝑟𝑒𝑑𝑢𝑐𝑒𝑑 − − − − − −(6.1)   
 
Figure 6.5 Effect of pH on Au|PMB-PPy in N2-purged PBS (v = 0.05 V s
-1
). 
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Table 6.2 Values of ∆Ep/V against pH of Au|PMB-PPy in N2-purged PBS. 
pH ∆Ep/ V 
4 0.135 
5 0.116 
6 0.098 
7 0.094 
8 0.070 
 
 
Figure 6.6 Chemical structure of MB
+
 dimer. 
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Figure 6.7 Electrochemical reduction of poly(MB
+
) to poly(LMB). 
 
 
Figure 6.8 (a) Chemical structure of MB
+
. (b) The electrochemical reduction of 
MB
+
 to LMB. 
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6.4.4 Electrochemical impedance spectroscopy of O2 biosensor in N2-purged 
PBS 
 The electrochemical impedance spectroscopy (EIS) of the Au|PMB-PPy 
(Figure 6.9a) was performed with an amplitude of 0.005 V from 0.01 Hz to 1.00 
MHz at the respective cathodic half-peak potential in N2-purged PBS of different 
pH to obtain the charge transfer resistance (Rct) and exchange current density (j0) in 
the kinetically controlled region of the CV and compared to that of a bare Au 
electrode (Figure 6.9b). At low frequencies, the data points deviate from the 
expected straight line due to natural convection. However, the maximum of each 
semicircle is visible and given by 𝑓 =
1
2𝜋𝑅𝑐𝑡 𝐶𝑑𝑙
 and Rct is twice the radius of the 
semicircle. The exchange current density is given by  𝑗0 =
𝑅𝑇
𝑛𝐹𝑅𝑐𝑡
. As seen in Figure 
6.10, the Rct of the Au|PMB-PPy and bare Au follow different trends and change 
with pH. However, they are still on the same order of magnitude, indicating that 
the presence of the film does not severely alter the Rct. From Table 6.3, the j0 of the 
Au|PMB-PPy are also similar to those of the bare Au. The double-layer capacitance 
(Cdl) of the Au|PMB-PPy is smaller than that of the bare Au as expected, indicating 
the presence of the film on the electrode. 
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Figure 6.9 EIS of (a) Au|PMB-PPy and (b) bare Au with amplitude of 0.005 V 
from 0.01 Hz to 1.00 MHz in N2-purged PBS from pH 4 to 8.  
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Figure 6.10 Plot of Rct x 10
5
/Ω against pH for Au|PMB-PPy (red circles) and bare 
Au (blue squares) in N2-purged PBS.  
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Table 6.3 Values of Rct x 10
5
/Ω, Cdl/µF and j0/µA cm
-2
 against pH for Au|PMB-
PPy and bare Au in N2-purged PBS.  
Electrode pH Rct x 10
5
/Ω Cdl/µF j0/µA cm
-2
 
Au|PMB-PPy 
8 2.917 3.069 2.802 
7 5.247 3.675 1.558 
6 4.199 4.593 1.947 
5 3.563 4.467 2.294 
4 1.970 3.095 4.149 
Bare Au 
8 2.654 7.264 3.079 
7 2.158 7.374 3.787 
6 1.944 8.185 4.204 
5 3.023 9.364 2.704 
4 4.241 9.796 1.927 
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6.4.5 Electrochemical characterisation of O2 biosensor in atm O2 PBS 
 The effect of PPy on the Au|PMB-PPy (Figure 6.11) is apparent when 
compared to the CV of Au|PMB (Figure S6). The presence of PPy causes the pair 
of peaks around 0.1 V and -0.1 V, which likely belongs to the MB
+
 monomer 
(Figure S6) to disappear. In addition, no anodic peak is observed for the Au|PMB-
PPy, indicating a catalytic reaction. The cathodic reaction of Au|PMB-PPy shows 
diffusion-limited behaviour as deduced from Figure 6.12, since the gradient is 
close to 0.5. Ep,c shifts negatively with increasing v and the plot of |ip,c|/v
0.5 
against v 
(Figure 6.13) reveals an electrochemical followed by catalytic reaction (EC') 
mechanism since |ip,c|/v
0.5
 falls with v [72]. It appears that PMB-PPy is 
electrochemically reduced and then rapidly reoxidised by dissolved O2.  
 
Figure 6.11 CV of Au|PMB-PPy in atm O2 PBS with different scan rates. 
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Figure 6.12 Plot of log(-ip,c)/A against log v/V s
-1
 for Au|PMB-PPy in atm O2 PBS. 
 
 
Figure 6.13 Plot of |ip,c|v
-0.5
 /µA V
-0.5
 s
0.5 
against v/V s
-1
 for Au|PMB-PPy in atm O2 
PBS. 
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6.4.6 Effect of pH on O2 biosensor in atm O2 PBS 
 pH is found to have negligible effects on the Au|PMB-PPy (Figure 6.14), 
thereby fulfilling the aim of making a pH-insensitive O2 biosensor. If the cathodic 
peak were to belong to the electrochemical reduction of dissolved O2, the reaction 
would be pH-dependent since O2 reduction requires H
+
. Since this is not so, the 
cathodic peak must belong to the electrochemical reduction of PMB-PPy described 
in equation 6.1 and this supports the EC' mechanism proposed earlier. The 
following equations describe the EC' mechanism of Au|PMB-PPy in atm O2 PBS, 
where PMB-PPy is first electrochemically reduced (equation 6.2a), then chemically 
reoxidised by dissolved O2 in a catalytic reaction (equation 6.2b), 
 𝑃𝑀𝐵 − 𝑃𝑃𝑦  𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑 + 𝑒− → [𝑃𝑀𝐵 − 𝑃𝑃𝑦] 𝑟𝑒𝑑𝑢𝑐𝑒𝑑 − − − − − − 6.2𝑎  
2  𝑃𝑀𝐵 − 𝑃𝑃𝑦  𝑟𝑒𝑑𝑢𝑐𝑒𝑑 + 𝑂2 +  2𝐻
+
→ 2 [𝑃𝑀𝐵 − 𝑃𝑃𝑦] 𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑 + 𝐻2𝑂2 − − − − − − − − − (6.2𝑏) 
The pH-independence of Au|PMB-PPy in N2-purged and atm O2 PBS is attributed 
to the synergistic effects of PMB and PPy, making it a promising material for 
detecting dissolved O2 even with fluctuating pH. 
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Figure 6.14 Effect of pH on Au|PMB-PPy in atm O2 PBS. 
 
 
6.4.7 Electrochemical impedance spectroscopy of O2 biosensor in atm O2 
PBS 
 The EIS was performed with an amplitude of 0.005 V from 0.01 Hz to 1.00 
MHz at the respective cathodic half-peak potential in atm O2 PBS of different pH 
for the Au|PMB-PPy (Figure 6.15a) and bare Au electrode (Figure 6.15b). From 
Figure 6.16 and Table 6.3, the Rct and j0 of the Au|PMB-PPy and bare Au are found 
to be similar. The Cdl of the Au|PMB-PPy is consistently smaller than the bare Au 
as expected. Comparing Table 6.4 to Table 6.3, Rct appears to decreases in the 
presence of O2.   
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Figure 6.15 EIS of (a) Au|PMB-PPy and (b) bare Au with amplitude of 0.005 V 
from 0.01 Hz to 1.00 MHz in atm O2 PBS from pH 4 to 8. 
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Figure 6.16 Plot of Rct x 10
5
/Ω against pH for Au|PMB-PPy (red circles) and bare 
Au (blue squares) in atm O2 PBS. 
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Table 6.4 Values of Rct x 10
5
/Ω, Cdl/µF and j0/µA cm
-2
 against pH for Au|PMB-
PPy and bare Au in atm O2 PBS.  
Electrode pH Rct x 10
5
/Ω Cdl/µF j0/µA cm
-2
 
Au|PMB-PPy 
8 0.969 1.989 8.432 
7 0.940 2.051 8.693 
6 1.004 2.326 8.138 
5 1.045 2.236 7.822 
4 1.044 2.237 7.827 
Bare Au 
8 0.885 4.696 9.240 
7 1.045 4.818 7.824 
6 0.907 4.582 9.016 
5 0.987 5.103 8.286 
4 0.939 5.363 8.709 
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6.4.8 CV of O2 biosensor in different concentrations of dissolved O2  
 Au|PMB-PPy (Figure 6.17a) and bare Au (Figure 6.17b) give comparable 
cathodic peak currents to different concentrations of dissolved O2, albeit at 
different peak potentials. In atm O2 PBS, the Au|PMB-PPy produces a single 
cathodic peak by the EC' mechanism while the bare Au gives 2 cathodic peaks as 
electrochemical reduction of O2 occurs as a 2-step reaction. In O2-saturated PBS, a 
peak at 0.04V is observed for the Au electrode, which might be the oxidation of 
H2O2. However, no such peak is observed for the Au|PMB-PPy. Although the 
cathodic peak potentials of Au|PMB-PPy are more negative than bare Au, the bare 
Au requires electrochemically cleaning between each measurement to give 
reproducible results while the Au|PMB-PPy does not. Bare Au is also susceptible 
to the adsorption of ions in the solution which causes its electrocatalytic properties 
to fall over time, while the Au|PMB-PPy is able to give consistent CVs when left 
soaked in PBS. Hence, the ability of Au|PMB-PPy to give peak currents 
comparable to bare Au in all three different concentrations of dissolved O2 makes it 
a promising O2 biosensor.  
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Figure 6.17 CV of (a) Au|PMB-PPy and (b) bare Au in N2-purged PBS (red), atm 
O2 PBS (blue) and O2-saturated PBS (brown) (v = 0.05 V s
-1
).  
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6.4.9 Amperometric detection of dissolved O2 
 The amperometric response of Au|PMB-PPy and bare Au to increasing 
dissolved O2 concentrations are compared (Figure 6.18). The concentration of 
saturated O2 in water is reported as 1.1 mM [274]. At 25 
0
C and atm pressure, the 
solubility of O2 in water is 8.24 mg L
-1
 [275] and the concentration of dissolved O2 
is therefore 0.258 mM. From Figure 6.19a, the sensitivity of the Au|PMB-PPy is 
found to be 244 µA mM
-1
 cm
-2
 (7.63 µA cm
-2
 mg
-1
 L) over a linear range of 0.014 
mM (0.448 mg L
-1
) to 0.254 mM (8.13 mg L
-1
) with a detection limit of 0.597 µM 
(0.0191 mg L
-1
) (S/N = 3) and has 90% response time of 12 s. In comparison, the 
bare Au has a sensitivity of 254 µA mM
-1
 cm
-2
 over a linear range of 0.014 mM to 
0.174 mM as seen in Figure 6.19b and has a 90% response time of 12 s. The 
Au|PMB-PPy outperforms the bare Au in terms of its linear range. The Au|PMB-
PPy also has superior sensitivity over other electrode materials listed in Table 6.5. 
The ability of Au|PMB-PPy to cover a linear range up to atm O2 outrivals that of 
other electrode materials and is highly important for physiological applications of 
the Au|PMB-PPy as an O2 biosensor. The Au|PMB-PPy was stable in storage at 4 
0
C in PBS over 18 days (Figure 6.20), which is superior to that of Au|PMB (Figure 
S6) and it retained 97% of its initial current response in atm O2 PBS.  
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Figure 6.18 Amperometric response of Au|PMB-PPy (red) and bare Au (blue) to 
successive additions of 100 µL O2-saturated PBS to 8 mL N2-purged PBS with 
magnetic stirring, which corresponds to 0.014 mM dissolved O2 per addition. The 
first addition was at 100 s (arrow) and additions were made every 50 s thereafter (V 
= -0.300 V). The insets show the current response/µA against time/s for the 
addition of 0.014 mM dissolved O2 to (a) bare Au and (b) Au|PMB-PPy. The 90% 
response time of both electrodes is 12 s.  
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Figure 6.19 Calibration plot of increase in cathodic current/µA against dissolved O2 
concentration/mM for (a) Au|PMB-PPy (n=3) and (b) bare Au. i is the increase in 
cathodic current in µA and c is the concentration of dissolved O2 in mM. 
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Figure 6.20 CV of Au|PMB-PPy in atm O2 PBS on the 1st day (red) and 18th day 
(blue) (v = 0.050 V s
-1
).  
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Table 6.5 Comparison of O2 biosensor performances 
Electrode materials Sensitivity/ 
µA cm
-2
 
mg
-1
 L 
Linear 
range/ 
mg L
-1
 
Detection  
limit/ 
mg L
-1
 
Ref. 
PMB-PPy 7.63 0.45-8.13 0.019 This 
work 
Mesoporous SiO2/C/cobalt 
(II) phthalocyanine 
2.16 0.50-6.60 0.010 [155] 
 
Layer-by-layer (iron(III) 
tetra-(N-methyl-4-pyridyl)-
porphyrin/tetrasulfonated 
phthalocyanine) 
4.12 0.20-6.40 0.060 [153] 
Anthraquinone-derivative 
functionalised multi-walled 
carbon nanotubes nanowires 
5.00 0.20-6.80 0.020 [157] 
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6.4.10 FESEM characterisation of glucose biosensor 
 The FESEM image of the PMB-PPy-GOD film is shown in Figure 6.21. 
This is different from the flat surface observed for PMB-PPy and the change arises 
from the presence of GOD. The resulting PMB-PPy-GOD has a wrinkled texture 
and the film appears interconnected, which might facilitate the movement of 
electrons across the polymer film.  
 
Figure 6.21 FESEM image (2200X) of PMB-PPy-GOD.  
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6.4.11 Electrochemical characterisation of glucose biosensor in N2-purged 
PBS 
 The Au|PMB-PPy-GOD exhibits a pair of redox peaks around -0.34 V and  
-0.24 V (Figure 6.22), which show diffusion-limited behaviour as inferred from 
Figure 6.23, since the gradients are close to 0.5. This behaviour is different from 
the surface voltammetry behaviour observed when GOD is adsorbed on the surface 
of the electrode [176]. As only one pair of peaks is observed, it is likely that the 
redox peaks of GOD(FAD/FADH2) are fused together with those of PMB-PPy. 
Like the Au|PMB-PPy, Ep,a remains rather constant, indicating a reversible 
reaction. Ep,c shifts negatively with increasing v (Figure 6.24), causing an increase 
in ∆Ep (Table 6.6) and this may imply a quasi-reversible reaction.  
 
Figure 6.22 CV of Au|PMB-PPy-GOD in N2-purged PBS with different scan rates. 
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Figure 6.23 Plot of log(-ip,c)/A against log v/V s
-1
 (red circles) and plot of log 
(ip,a)/A against log v/V s
-1
 (blue squares) for Au|PMB-PPy-GOD in N2-purged 
PBS. 
 
Figure 6.24 Plot of Ep,c/V (red circles) and Ep,a/V (blue squares) against v/V s
-1
 for 
Au|PMB-PPy-GOD in N2-purged PBS. 
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Table 6.6 Values of E
0
'/V and ∆Ep/V against scan rate/ V s
-1
.
 
 
Scan rate/ V s
-1
 E
0
'/ V ∆Ep/ V 
0.005 -0.273 0.065 
0.010 -0.272 0.071 
0.025 -0.273 0.074 
0.050 -0.276 0.078 
0.075 -0.277 0.081 
0.100 -0.277 0.085 
0.200 -0.281 0.090 
0.300 -0.281 0.102 
0.400 -0.286 0.103 
0.500 -0.290 0.113 
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6.4.12 Effect of pH on glucose biosensor in N2-purged PBS and direct electron 
transfer of glucose oxidase 
 pH has an interesting effect on the peaks (Figure 6.25). A pair of peaks is 
observed from pH 6 to 8 but these split into two pairs of peaks at pH 4 and 5. From 
the pH behaviour of Au|PMB-PPy (Figure 6.5), we can deduce that the pair of 
peaks at more negative potential at pH 4 and 5 belong to PMB-PPy since they 
display sub-Nernstian response towards pH, while the extra pair of peaks seen at 
less negative potentials must belong to the direct electron transfer (DET) of GOD. 
The DET of GOD refers to the ability of GOD(FADH2) to be electrochemically 
oxidised to GOD(FAD) [176], which is a key feature of third generation glucose 
biosensor and important for its operation under hypoxic conditions.  
 
Figure 6.25 Effect of pH on Au|PMB-PPy-GOD in N2-purged PBS (v = 0.05 V s
-1
). 
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 Indeed, Ep,c shifts negatively by -0.062 V pH
-1 
from pH 4 to 5, which is very 
close to that expected for the Nernstian behaviour of GOD(FAD/FADH2) towards 
pH. In addition, the ∆Ep for this pair of peaks is 0.053V at pH 4 and 0.037V at pH 
5, indicating that the redox reaction involves more than 1 e
-
 transfer. The following 
equations describe the redox behaviour of PMB-PPy-GOD. 
From pH 6 to 8: 
  𝑃𝑀𝐵 − 𝑃𝑃𝑦  𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑 − 𝐺𝑂𝐷 𝐹𝐴𝐷  + 3𝑒− + 2𝐻+
→ {[𝑃𝑀𝐵 − 𝑃𝑃𝑦] 𝑟𝑒𝑑𝑢𝑐𝑒𝑑 − 𝐺𝑂𝐷 𝐹𝐴𝐷𝐻2 } − − − − − −(6.3) 
From pH 4 to 5: 
  𝑃𝑀𝐵 − 𝑃𝑃𝑦  𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑 − 𝐺𝑂𝐷 𝐹𝐴𝐷  + 2𝑒− + 2𝐻+
→ {[𝑃𝑀𝐵 − 𝑃𝑃𝑦] 𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑 − 𝐺𝑂𝐷 𝐹𝐴𝐷𝐻2 } − − − − − (6.4𝑎) 
{ 𝑃𝑀𝐵 − 𝑃𝑃𝑦  𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑 − 𝐺𝑂𝐷 𝐹𝐴𝐷𝐻2 } + 𝑒
−
→ { 𝑃𝑀𝐵 − 𝑃𝑃𝑦  𝑟𝑒𝑑𝑢𝑐𝑒𝑑 − 𝐺𝑂𝐷 𝐹𝐴𝐷𝐻2 } − − − − − (6.4𝑏) 
From pH 6 to 8, the electrochemical reduction of PMB-PPy-GOD occurs as a 
single step and shows sub-Nernstian response to pH (equation 6.3). However, at 
pH 4 and 5, the GOD(FAD) is first electrochemically reduced (equation 6.4a), 
followed by the electrochemical reduction of PMB-PPy (equation 6.4b).  
 The sub-Nernstian behaviour of PMB-PPy-GOD towards pH from pH 6 to 
8 makes it attractive for use under physiological conditions where the pH is not 
expected to fall below 6. Such unique behaviour for a third generation glucose 
biosensor is attributed to the use of the pH-insensitive PMB-PPy. It is possible that 
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the positively charged PMB and PPy and their monomers interact electrostatically  
with the negatively charged GOD during electropolymerisation and establish an 
electrically conductive path to the FAD/FADH2 redox centre of GOD in the 
resulting PMB-PPy-GOD, giving rise to the DET of GOD. 
 
6.4.13 Direct electron transfer of glucose oxidase in N2-purged glucose 
solutions 
 The addition of glucose produces a decrease in ip,c and increase in ip,a as 
expected (Figure 6.26), demonstrating that the pair of peaks involve the DET of 
GOD(FAD/FADH2) and verifies that the Au|PMB-PPy-GOD is a third generation 
glucose biosensor. The reaction of the Au|PMB-PPy-GOD in the N2-purged 
glucose solutions can be described as such, 
 𝑃𝑀𝐵 − 𝑃𝑃𝑦 − 𝐺𝑂𝐷 𝐹𝐴𝐷  + 𝐺𝑙𝑢𝑐𝑜𝑠𝑒 
            →  𝑃𝑀𝐵 − 𝑃𝑃𝑦 − 𝐺𝑂𝐷 𝐹𝐴𝐷𝐻2  + 𝐺𝑙𝑢𝑐𝑜𝑛𝑜𝑙𝑎𝑐𝑡𝑜𝑛𝑒 − − − − − (6.5𝑎) 
  𝑃𝑀𝐵 − 𝑃𝑃𝑦  𝑟𝑒𝑑𝑢𝑐𝑒𝑑 − 𝐺𝑂𝐷 𝐹𝐴𝐷𝐻2   
             →  [𝑃𝑀𝐵 − 𝑃𝑃𝑦] 𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑 − 𝐺𝑂𝐷 𝐹𝐴𝐷  + 3𝑒− + 2𝐻+ − − − (6.5𝑏) 
The PMB-PPy-GOD reacts enzymatically with glucose and GOD(FAD) is reduced 
(equation 6.5a). The PMB-PPy component of the PMB-PPy-GOD may exist as 
mixture of oxidised and reduced states if they contribute electrons towards the 
enzymatic reaction. During the negative scan of the CV, PMB-PPy-GOD is 
electrochemically reduced according to equation 6.3. ip,c decreases with increasing 
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glucose concentration since more of the PMB-PPy-GOD are already in their 
reduced state after the enzymatic reaction with glucose. Therefore, on the positive 
scan of the CV, ip,a increases with higher glucose concentration due to the greater 
amount of reduced PMB-PPy-GOD. This demonstrates the DET of GOD, where 
reduced GOD is reoxidised according to equation 6.5b.  
 
Figure 6.26 CV of Au|PMB-PPy-GOD in PBS and different concentrations of 
glucose purged with N2 (v = 0.05 V s
-1
).   
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6.4.14 Electrochemical characterisation of glucose biosensor in atm O2 PBS 
 The CV of Au|PMB-PPy-GOD is shown in Figure 6.27. Au|PMB-PPy-
GOD shows diffusion-limited behaviour, as inferred from Figure 6.28, since the 
gradient is close to 0.5. Ep,c shifts negatively with increasing v and Au|PMB-PPy-
GOD is found to exhibit the EC' mechanism since |ip,c|v
-0.5
 falls with increasing v 
(Figure 6.29). The EC' mechanism of Au|PMB-PPy-GOD can be described by the 
following equations, where PMB-PPy-GOD is electrochemically reduced (equation 
6.6a) and then catalytically regenerated by dissolved O2 (equation 6.6b).  
{[𝑃𝑀𝐵 − 𝑃𝑃𝑦] 𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑 − 𝐺𝑂𝐷 𝐹𝐴𝐷 } + 3𝑒− + 2𝐻+ 
          →  [𝑃𝑀𝐵 − 𝑃𝑃𝑦] 𝑟𝑒𝑑𝑢𝑐𝑒𝑑 − 𝐺𝑂𝐷 𝐹𝐴𝐷𝐻2  − − − − − − − − − (6.6𝑎) 
2 [𝑃𝑀𝐵 − 𝑃𝑃𝑦] 𝑟𝑒𝑑𝑢𝑐𝑒𝑑 − 𝐺𝑂𝐷 𝐹𝐴𝐷𝐻2  + 3𝑂2 + 6𝐻
+ 
          → 2 [𝑃𝑀𝐵 − 𝑃𝑃𝑦] 𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑 − 𝐺𝑂𝐷 𝐹𝐴𝐷  + 3𝐻2𝑂2  − − − − − (6.6𝑏) 
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Figure 6.27 CV of Au|PMB-PPy-GOD in atm O2 PBS with different scan rates. 
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Figure 6.28 Plot of log(-ip,c)/A against log v/V s
-1
 for Au|PMB-PPy-GOD in atm O2 
PBS. 
 
Figure 6.29 Plot of |ip,c|v
-0.5
 /µA V
-0.5
 s
0.5 
against v/V s
-1
 for Au|PMB-PPy-GOD in 
atm O2 PBS.  
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6.4.15 Effect of pH on glucose biosensor in atm O2 PBS 
 The effect of pH on Au|PMB-PPy-GOD is different in atm O2 PBS (Figure 
6.30) and N2-purged PBS (Figure 6.25). Here, Au|PMB-PPy-GOD appears 
insensitive to pH, as expected from equation 6.6a. The presence of dissolved O2 
clearly alters the electrochemical behaviour of the Au|PMB-PPy-GOD. The extra 
pair of peaks belonging to GOD(FAD/FADH2) at pH 4 and 5 in N2-purged PBS 
(Figure 6.25) are not seen here. While a small peak is observed at around -0.1V, 
this is similar to the one for Au|PMB-PPy (Figure 6.14) and likely arises from the 
PMB-PPy and not the GOD. The insensitivity of Au|PMB-PPy-GOD to pH in atm 
O2 PBS highlights its great potential for use even with fluctuations in physiological 
pH levels as long as the supply of atm O2 is maintained.  
 
Figure 6.30 Effect of pH on Au|PMB-PPy-GOD in atm O2 PBS (v = 0.05 V s
-1
). 
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6.4.16  CV of glucose biosensor in different concentrations of glucose  
 The behaviour of Au|PMB-PPy-GOD to different concentrations of glucose 
at atm O2 is investigated (Figure 6.31). The reaction still appears to follow the EC' 
mechanism. ip,c decreases while ip,a increases when glucose concentration is higher. 
PMB-PPy-GOD first reacts enzymatically with glucose according to equation 6.5a 
and is reduced. During the negative scan of the CV, any remaining PMB-PPy-GOD 
is electrochemically reduced. When glucose concentration is high, most of the 
PMB-PPy-GOD is already reduced following the enzymatic reaction, therefore ip,c 
is smaller in magnitude. The reduced PMB-PPy-GOD is then catalytically 
regenerated by its reaction with dissolved O2 according to equation 6.6b. 
 
Figure 6.31 CV of Au|PMB-PPy-GOD in PBS and different concentrations of 
glucose at atm O2 (v = 0.05 V s
-1
).   
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6.4.17 Amperometric response of glucose biosensor 
 The amperometric detection of glucose using the Au|PMB-PPy-GOD was 
carried out at atm O2 and achieved a 90% response time of 7 s (Figure 6.32). The 
calibration plot is given in Figure 6.33 and the Lineweaver-Burk plot is shown in 
Figure 6.34. The Lineweaver-Burk expression [176] of the Michaelis-Menten 
equation is given by the equation   
1
𝑖𝑠𝑠
=
𝐾𝑀
𝑎𝑝𝑝
𝑖𝑚𝑎𝑥
1
𝑐
+
1
𝑖𝑚𝑎𝑥  
 
where iss is the steady-state current, KM
app
 is the apparent Michaelis-Menten 
constant, c is the substrate concentration and imax is the maximum current. 
 From Figure 6.32, the decrease in cathodic current prior to the first addition 
of glucose represents the consumption of dissolved O2 to regenerate the reduced 
PMB-PPy-GOD in the absence of glucose, since PMB-PPy-GOD is also sensitive 
to dissolved O2 concentrations. Hence, the baseline current for the calibration plot 
is taken at the foot of the current spike due to the first addition of glucose. From 
Figure 6.33, the sensitivity is 6.06 µA mM
-1 
cm
-2
 from 0.25 mM to 1.49 mM 
glucose with a detection limit of 29.7 µM glucose (S/N = 3) and the KM
app
 is 9.60 
mM (Figure 6.34). As the concentration of glucose increases further, there are 
fewer free active sites of GOD to catalyse the reaction of glucose to 
gluconolactone, hence the sensitivity falls beyond 1.49 mM glucose. Nonetheless, 
Au|PMB-PPy-GOD still offers higher sensitivity and lower detection limit over 
most of the electrode materials listed in Table 6.7. 
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 From Figure 6.35, 10 mM ascorbic acid (AA) and 10 mM uric acid (UA) 
show negligible interferences on the average current responses of 0.25 mM 
glucose. The Au|PMB-PPy-GOD was stable in storage at 4 
0
C in PBS over 29 days 
(Figure 6.36).  
 
Figure 6.32 Amperometric response of Au|PMB-PPy-GOD to successive additions 
of 10µL 250 mM glucose to 10 mL of atm O2 PBS with magnetic stirring, which 
corresponds to 0.25 mM glucose per addition. The first addition was at 50 s (arrow) 
and additions were made every 30 s thereafter (V = -0.360 V). The inset shows the 
current response/µA against time/s of the Au|PMB-PPy-GOD to the addition of 
0.25 mM glucose. The 90% response time is 7 s.  
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Figure 6.33 Calibration plot of decrease in cathodic current/µA against glucose 
concentration/mM for Au|PMB-PPy-GOD in atm O2 (n=3). i is the decrease in 
cathodic current in µA and c is the concentration of glucose in mM. 
 
Figure 6.34 Lineweaver-Burk plot corresponding to the linear range of 0.25 mM to 
1.49 mM glucose. iss is the decrease in cathodic current in µA and c is the 
concentration of glucose in mM.  
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Figure 6.35 Current response of Au|PMB-PPy-GOD to 0.25 mM glucose vs. the 
interfering species, 10 mM ascorbic acid (AA) and 10 mM uric acid (UA) (n=3). 
 
Figure 6.36 CV of Au|PMB-PPy-GOD in atm O2 PBS on the 1st day (red) and 29th 
day (blue) (v = 0.050 V s
-1
).  
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Table 6.7 Comparison of glucose biosensor performances 
Electrode materials Sensitivity/ 
µA mM
-1
 cm
-2
  
Linear 
range/ 
mM 
Detection  
limit/ 
µM 
Ref. 
PMB-PPy-GOD 6.06 0.25-1.49 29.7 This 
work     
Poly(N[3-(trimethoxysilyl) 
propyl]aniline)/horse radish 
protein-GOD 
0.16 1.00-20.00 100 [276] 
TiO2/carbon nanotubes/     
Pt nanoparticles/GOD 
0.24 0.006-1.50 5.70 [277] 
Layer-by-layer (Au 
nanoparticles/thionine)/ 
GOD/horse radish protein 
3.80 0-3.00 35.0 [114] 
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6.5 Conclusion 
 An O2 biosensor, Au|PMB-PPy, and a glucose biosensor, Au|PMB-PPy-
GOD, were prepared by one-step electropolymerisation of MB
+
 and pyrrole, with 
the addition of GOD to prepare the glucose biosensor. The presence of pyrrole not 
only prevents the formation of MB
+
 monomers in the polymer film and gives rise 
to its EC' mechanism, but also improves the stability of the polymer film. The O2 
biosensor (Au|PMB-PPy) demonstrates a superior sensitivity of 244 µA mM
-1
 cm
-2
 
over a linear range of 0.014 mM to 0.254 mM and has a detection limit of 0.597 
µM (S/N = 3). It has a 90% response time of 12 s and good stability of 18 days. 
Notably, the Au|PMB-PPy is pH-insensitive in N2-purged and atm O2 PBS from 
pH 4 to 8 and is highly promising for use in physiological conditions where pH 
fluctuations are expected. The glucose biosensor (Au|PMB-PPy-GOD) exhibits 
DET of GOD in N2-purged PBS and glucose solutions. It possesses a sensitivity of 
6.06 µA mM
-1
 cm
-2
 in the linear range of 0.25 mM to 1.49 mM glucose with a 
detection limit of 29.7 µM glucose (S/N = 3). It has a 90% response time of 7 s and 
stability over 29 days. The Au|PMB-PPy-GOD is pH-insensitive in N2-purged PBS 
from pH 6 to 8 and atm O2 PBS from pH 4 to 8, highlighting its potential for use in 
physiological pH conditions. The two biosensors prepared here are feasible for 
future miniaturisation on lab-on-a-chip to probe the effect of the degree of hypoxia 
on the glucose uptake of ECs in real-time. 
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7 Overall conclusion and perspectives 
 Four works have been presented in this dissertation, which encompasses the 
design of nanomaterials-based electrochemical biosensors capable of the real-time, 
quantitative detection of the signalling molecule, NO, and metabolic markers, pH, 
O2 and glucose, which are involved in angiogenesis. These biosensors are useful 
for studying the acute cellular responses of endothelial cells (ECs) to external 
stimuli, to gain a better understanding of angiogenesis. In addition, some of these 
biosensors have been shown to be biocompatible for the culture of ECs and are 
able to operate in cell culture medium.  
 In the first work, 3-D graphene/IL nanocomposite shows highly sensitive 
detection of NO in phosphate buffered saline (PBS) and its performance is superior 
to that of gold nanoparticles (AuNPs) and carbon nanotubes (CNTs).  
 In the second work, an arginine-glycine-aspartic acid (RGD)-peptide-
functionalised biomimetic graphene film which functions as both a cell culture and 
sensing matrix is developed. Human umbilical vein endothelial cells (HUVECs) 
were cultured on the biomimetic graphene film and the NO released by these cells 
under acetylcholine (Ach) stimulation and NG-nitro-L-arginine methyl ester (L-
NAME) inhibition were detected in real-time in cell culture medium. Ach 
increased the amount of NO released in a dose-dependent manner while L-NAME 
inhibited the release of NO, thereby providing insights to the real-time interactions 
between HUVECs and soluble drug molecules and the resulting release of NO.  
 In the third work, poly(ethyleneimine) (PEI)-coated anodically 
electrodepositied iridium oxide film (AEIROF) on a chip functions as a  miniature 
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potentiometric pH sensor and exhibits super-Nernstian response to pH. The 
interaction of thrombin, porcine endothelial cells (PAECs) and fibronectin and 
their resulting changes to extracellular pH was investigated in real-time on-chip in 
cell culture medium. The pH falls as thrombin cause dissolution of fibronectin and 
extracellular acidification of PAECs, changing their morphology from stretched to 
round cells. PD98059, a mitogen-activated protein (MAP) kinase inhibitor, reduced 
extracellular acidification, indicating that thrombin acts through a MAP kinase-
dependent pathway in PAECs to increase extracellular acidification. Thrombin not 
only causes ECs to lose their anchorage, but also acutely increases EC metabolism 
and cytoskeleton reorganisation, likely in preparation of cell proliferation and 
migration in thrombin-mediated angiogenesis. 
 Lastly, a novel electropolymerised redox polymer prepared from a 
precursor solution of methylene blue (MB
+
) and pyrrole was used to fabricate an 
O2 biosensor, with the addition of glucose oxidase (GOD) to the precursor solution 
for a glucose biosensor. The O2 biosensor (Au|PMB-PPy) demonstrates superior 
sensitivity towards the detection of dissolved O2 at atm O2 concentration and 
below. Notably, it is insensitive to pH in both N2-purged and atm O2 PBS from pH 
4 to 8. The glucose biosensor (Au|PMB-PPy-GOD) exhibits direct electron transfer 
(DET) of GOD and is insensitive to pH from pH 6 to 8 in N2-purged PBS and from 
pH 4 to 8 in atm O2 PBS. Since these biosensors can operate without O2, they are 
potentially useful for probing EC metabolism changes in relation to hypoxia during 
angiogenesis. In addition, their insensitivity to pH make them advantageous for 
studying EC metabolism studies where changes in physiological pH are expected. 
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Their ease of miniaturisation allow their potential application for the simultaneous 
detection of O2 and glucose of ECs on lab-on-a-chip devices.  
 Despite the overall good performances of these biosensors, each biosensor 
has its own limitations and improvements need to be made to overcome these 
problems. The 3-D graphene/IL nanocomposite on a glassy carbon electrode is 
unsuitable for detecting NO released by ECs on a cell culture dish as it will take 
too long for NO to diffuse from the ECs to the electrode since the diffusion 
coefficient of NO is likely to be on the order of 10
-6
 cm
2
 s
-1
. This can be overcome 
by screen-printing the nanocomposite on a chip and culturing ECs on it so that any 
NO released by the ECs is almost immediately detected by the electrode. The 
biocompatibility of the 3-D graphene/IL for EC attachment and growth also needs 
to be evaluated.  
 The surface area used for the detection of NO released by the HUVECs on 
the RGD-peptide-functionalised biomimetic graphene film was limited by the 
diameter of the columniform. It will be better to increase the surface area used for 
detecting NO released by HUVECS by using a customised columniform of larger 
diameter. This will give a more reliable average value for the concentration of NO 
released by HUVECs per unit area since cell distribution may vary across the film.  
 The PEI-coated AEIROF was unable to measure the exact pH value of the 
cell culture medium unlike in phosphate buffer due to the unexpected change in 
formal potential following coating with fibronectin and incubation. This limited its 
use in the cell experiments to measuring changes in pH. The cause of this problem 
needs to be investigated. The incubator can be set to 25 
0
C to minimise any impact 
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that the heat could have on the film but the viability and attachment of the PAECs 
to the chip at 25 
0
C would also need to be evaluated. The experimental setup can be 
improved with inlets for the addition of chemicals to the chip so that the chip does 
not have to be disconnected from the setup for the chemicals to be added.  
 The linear range of the glucose biosensor can be improved by adding more 
GOD to the precursor solution, so that there will be more GOD present on the 
biosensor to catalyse the reaction of glucose to gluconolactone at higher 
concentrations of glucose. The calibration of the glucose biosensor needs to be 
done in different levels of O2 below atm O2 in order to use the O2 and glucose 
biosensors simultaneously. The biocompatibility of the O2 biosensor and glucose 
biosensor for EC culture have not been evaluated.  
 For future works, the addition of a lactate biosensor will allow a more 
comprehensive investigation into the rate of EC metabolism since lactate is a by-
product of glucose metabolism in ECs. The lactate biosensor can be fabricated 
using a procedure similar to the glucose biosensor by adding lactate oxidase to the 
precursor solution of MB
+
 and pyrrole.  
 The biosensors in this dissertation have been used individually. However, it 
would be even more meaningful to use two or more of them simultaneously so as 
to build a more comprehensive picture of the crosstalk between EC metabolism and 
angiogenesis. One way is to use lab-on-a-chip devices to miniaturise these sensors 
by screen-printing, electrodeposition or electropolymerisation, such as that 
proposed for the O2 and glucose biosensors. Thereafter, ECs are cultured on these 
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electrodes, which simultaneously detect the various metabolic markers and NO as 
the cells are exposed to drugs or soluble factors.  
 Since shear stress also affects angiogenesis [278], its effects can be 
investigated along with soluble factors and the extracellular matrix (ECM) 
macromolecules to achieve a greater understanding of angiogenesis in real-time. 
This can be done by varying the flow rate of cell culture medium to the chip and 
observing the morphology of the ECs and measuring the levels of metabolic 
markers.  
 More work needs to be done to having a better understanding of both the 
spatial and temporal uptake and release of soluble factors and signalling molecules 
by the ECs, respectively. The use of fluorescently tagged soluble factors can enable 
visualisation of when these factors bind to ECs. The time between their binding to 
the cells to the detection of signalling molecules can also be studied. The signalling 
molecules can be detected on various locations on a chip in real-time by using an 
array of microelectrodes.  
 The autocrine and paracrine effects of these factors and molecules and how 
they alter EC metabolism and angiogenesis in real-time also need to be 
investigated. Autocrine effects (effects which biomolecules have on the cell which 
produces them) can be studied by inhibiting enzymes involved in the biochemical 
reactions downstream of the intracellular signalling pathway of interest. Paracrine 
effects (effects which biomolecules produced by a cell have on its neighbours) can 
be investigated by separating the ECs into colonies and inhibiting receptors 
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involved in the uptake of the biomolecule of interest by the neighbouring colony of 
ECs.    
 In conclusion, the fabrication of nanomaterials-based electrochemical 
biosensors for NO, pH, O2 and glucose with good performances have been 
accomplished in this dissertation. I have shown how some of these electrochemical 
biosensors are biocompatible and useful for studying the interactions of soluble 
factors, ECs and ECM macromolecules in cell culture medium. Through the use of 
drugs and inhibitors whose actions are well understood, the intracellular pathways 
through which the soluble factor elicits an acute metabolic response from the ECs 
can be probed, and this is significant in gaining insights to the processes involved 
in angiogenesis. I have also discussed the limitations and improvements to be made 
to these biosensors, which will enable us to gain a better understanding of 
angiogenesis in the near future. These biosensors also have the potential for 
application to studying the acute cellular responses of other cell types to external 
stimuli.    
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List of Abbreviations 
 
a Activity 
AA Ascorbic acid 
Ach Acetylcholine 
AEIROF Anodically electrodeposited iridium oxide film 
AFM Atomic force microscopy 
AIROF Anodic iridium oxide film 
Ang Angiopoietins 
Atm Atmospheric 
ATP Adenosine triphosphate 
c Bulk concentration 
CcO Cytochrome c oxidase 
Cdl Double layer capacitance 
CNTs Carbon nanotubes 
CoPc Cobalt(II) phthalocyanine 
CV Cyclic voltammetry 
CVD Chemical vapour deposition 
δ Thickness of the Nernst diffusion layer 
D Diffusion coefficient 
DET Direct electron transfer 
DI De-ionised 
Dll4 Delta-like ligand 4 
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DMEM Dulbecco's Modified Eagle's Medium 
DNA Deoxyribonucleic acid 
DPBS Dulbecco's phosphate buffered saline 
DPSCA Double potential step chronoamperometry 
∆Ep Peak separation  
E
0
 Standard potential 
E
0
' Formal potential 
EC' Electrochemical followed by catalytic reaction 
ECs Endothelial cells 
ECM Extracellular matrix 
EDC Ethyl(dimethylaminopropyl) carbodiimide 
EIS Electrochemical impedance spectroscopy 
eNOS Endothelial nitric oxide synthase 
Ep Peak potential 
Ep,a Anodic peak potential 
Ep,c Cathodic peak potential 
Erk Extracellular receptor kinase 
f Frequency 
F Faraday's constant 
FAD Flavin adenine dinucleotide 
FADH2 Reduced flavin adenine dinucleotide 
FAK Focal adhesion kinase 
FESEM Field emission scanning electron microscopy 
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FGF Fibroblasts growth factor 
FITC Fluorescein isothiocyanate mixed isomer 
FTIR Fourier transform infrared 
GC Glassy carbon 
GO Graphene oxide 
GOD Glucose oxidase 
HIF Hypoxia inducible factor 
HOOC-2-
AQ/AMWCNTs 
Anthraquinone-derivative functionalised MWCNTs 
nanowires 
HUVECs Human umbilical vein endothelial cells 
IL Ionic liquid 
iNOS Inducible nitric oxide synthase 
imax Maximum current 
ip Peak current 
ip,a Anodic peak current 
ip,c Cathodic peak current 
IrOx Iridium oxide 
iss Steady-state current 
J Flux 
j0 Exchange current density 
KM
app
 Apparent Michaelis-Menten constant 
LBL Layer-by-layer 
LMB Leuco methylene blue 
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L-NAME NG-nitro-L-arginine methyl ester 
m Mass transport coefficient 
MAPK Mitogen-activated protein kinase 
MB
+
 Methylene blue 
MEA Microelectrode array 
MWCNTs Multi-walled carbon nanotubes 
n Number of electrons 
n Number of repeats 
NADH Nicotinamide adenine dinucleotide 
NHS N-hydroxysulfosuccinimide 
NO Nitric oxide 
NPs Nanoparticles 
OCP Open circuit potential 
∅ Phase shift 
PAECs Porcine aortic endothelial cells 
PBS Phosphate buffered saline 
PDGF Platelet-derived growth factor 
PD98059 MAP kinase inhibitor 
PEDG Pigment epithelium-derived factor 
PEI Poly(ethyleneimine) 
PHD-2 Protein hydroxylase domain containing protein 2 
PI3K Phosphatidylinositol 3-kinase 
PIP3 Phosphatidylinositol (3,4,5)P3 
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PLL Poly(L-lysine) 
PKB Protein kinase B 
PKC Protein kinase c 
PMB Poly(methylene blue) 
PPy Poly(pyrrole) 
R Gas constant 
Rct Charge transfer resistance 
RA-IR Reflection absorption infrared spectroscopy 
Ref. Reference 
RGD Arginine-glycine-aspartic acid 
rGO Reduced graphene oxide 
Ru Uncompensated resistance 
SIROF Sputtered iridium oxide film 
S/N Signal-to-noise ratio 
SWCNTs Single-walled carbon nanotubes 
t Time 
T Temperature 
TeTsPc Iron(III) tetra-(N-methyl-4-pyridyl)-porphyrin 
FeT4MPyP Iron tetrasulfonated phthalocyanine 
UA Uric acid 
v Scan rate 
VEGF Vascular endothelial growth factor 
VEGFR Vascular endothelial growth factor receptor 
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Z Charge 
2-D Two-dimensional 
3-D Three-dimensional 
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